10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

____________

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2014
OR
¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _________to_________

Commission File Number

000-23115

CTI INDUSTRIES CORPORATION

(Exact name of Registrant as specified in its charter)

Illinois	36-2848943
(State or other jurisdiction of	(I.R.S. Employer Identification Number)
incorporation or organization)
22160 N. Pepper Road
Lake Barrington, Illinois	60010
(Address of principal executive offices)	(Zip Code)

(847) 382-1000

(Registrant’s telephone number, including area code)

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes þ     No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ     No ¨

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer, or a smaller reporting company. See definition of “large accelerated filer”, “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer ¨ Accelerated filer ¨ Non-accelerated filer ¨ Smaller Reporting Company þ

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes ¨     No þ

The number of shares outstanding of the Registrant’s common stock as of November 1, 2014 was 3,301,116.

INDEX

Part I – Financial Information

Item No. 1.	Financial Statements
	Condensed Consolidated Interim Balance Sheets at September 30, 2014 (unaudited) and December 31, 2013	1
	Condensed Consolidated Interim Statements of Comprehensive Income (unaudited) for the three and nine months ended September 30, 2014 and September 30, 2013	2
	Condensed Consolidated Interim Statements of Cash Flows (unaudited) for the nine months ended September 30, 2014 and September 30, 2013	3
	Condensed Consolidated Interim Earnings per Share (unaudited) for the three and nine months ended September 30, 2014 and September 30, 2013	4
	Notes to Condensed Consolidated Financial Statements (unaudited)	5
Item No. 2	Management’s Discussion and Analysis of Financial Condition and Results of Operations	15
Item No. 3	Quantitative and Qualitative Disclosures Regarding Market Risk	23
Item No. 4	Controls and Procedures	23
Part II – Other Information
Item No. 1	Legal Proceedings	23
Item No. 1A	Risk Factors	24
Item No. 2	Unregistered Sales of Equity Securities and Use of Proceeds	24
Item No. 3	Defaults Upon Senior Securities	24
Item No. 4	Submission of Matters to a Vote of Security Holders	24
Item No. 5	Other Information	24
Item No. 6	Exhibits	24
	Signatures
	Exhibit 31.1
	Exhibit 31.2
	Exhibit 32

PART 1 - FINANCIAL INFORMATION

Item 1. Financial Statements

CTI Industries Corporation and Subsidiaries

Condensed Consolidated Balance Sheets 

	September 30, 2014			December 31, 2013
ASSETS	(unaudited)
Current assets:
Cash and cash equivalents (VIE $26,000 and $54,000, respectively)	$	171,843		$	666,616
Accounts receivable, (less allowance for doubtful accounts of $263,000		11,114,047			8,883,106
and $217,000, respectively) (VIE $6,000 and $0, respectively)
Inventories, net (VIE $724,000 and $390,000, respectively)		18,400,506			15,428,413
Net deferred income tax asset		836,792			931,245
Prepaid expenses (VIE $3,000 and $3,000, respectively)		1,181,254			1,315,384
Other current assets (VIE $74,000 and $76,000, respectively)		706,459			945,914
Total current assets		32,410,901			28,170,678
Property, plant and equipment:
Machinery and equipment (VIE $700,000 and $723,000, respectively)		27,187,213			26,639,722
Building		3,360,017			3,360,017
Office furniture and equipment (VIE $44,000 and $39,000, respectively)		3,463,299			3,287,951
Intellectual property		482,088			482,088
Land		250,000			250,000
Leasehold improvements		655,720			586,515
Fixtures and equipment at customer locations		3,012,013			2,784,419
Projects under construction		793,236			1,009,623
		39,203,586			38,400,335
Less: accumulated depreciation and amortization (VIE $128,000 and $92,000, respectively)		(31,191,753	)		(29,718,564	)
Total property, plant and equipment, net		8,011,833			8,681,771
Other assets:
Deferred financing costs, net		147,601			197,585
Goodwill (VIE $440,000 and $440,000, respectively)		1,473,176			1,473,176
Net deferred income tax asset		858,434			317,639
Other assets (due from related party $23,000 and $24,000, respectively)		162,818			230,651
Total other assets		2,642,029			2,219,051
TOTAL ASSETS	$	43,064,763		$	39,071,500
LIABILITIES AND EQUITY
Current liabilities:
Checks written in excess of bank balance (VIE $3,000 and $0, respectively)	$	1,044,151		$	704,757
Trade payables (VIE $120,000 and $94,000, respectively)		5,579,077			3,573,007
Line of credit (VIE $497,000 and $219,000, respectively)		11,654,227			8,769,024
Notes payable - current portion (net discount of $141,000 and $125,000, repectively)
(VIE $112,000 and $107,000, respectively)		332,710			342,931
Notes payable affiliates - current portion		9,604			9,079
Capital Lease - current portion		32,084			30,487
Accrued liabilities (VIE $78,000 and $73,000, respectively)		2,473,569			3,003,704
Total current liabilities		21,125,422			16,432,989
Long-term liabilities:
Notes payable - affiliates		282,044			281,148
Notes payable, net of current portion (net discount of $322,000 and $430,000, repectively)
(VIE $351,000 and $441,000, respectively)		7,258,199			7,511,383
Notes payable - officers, subordinated		1,215,748			1,155,705
Capital Lease		85,404			109,670
Total long-term debt, net of current portion		8,841,395			9,057,906
Warrants Payable		544,787			816,480
Total long-term liabilities		9,386,182			9,874,386
Equity:
CTI Industries Corporation stockholders' equity:
Preferred Stock -- no par value 2,000,000 shares  authorized
0 shares issued and outstanding		-			-
Common stock  - no par value, 5,000,000 shares authorized,
3,376,743 and 3,320,773 shares issued and 3,301,116 and 3,248,646
outstanding, respectively		13,585,994			13,775,994
Paid-in-capital		1,715,738			1,165,549
Accumulated earnings		241,587			109,137
Accumulated other comprehensive loss		(2,805,515	)		(2,253,501	)
Less:  Treasury stock, 75,627 and 72,127 shares, respectively		(160,784	)		(141,289	)
Total CTI Industries Corporation stockholders' equity		12,577,020			12,655,890
Noncontrolling interest		(23,861	)		108,235
Total Equity		12,553,159			12,764,125
TOTAL LIABILITIES AND EQUITY	$	43,064,763		$	39,071,500

See accompanying notes to condensed consolidated unaudited financial statements

1

CTI Industries Corporation and Subsidiaries

Condensed Consolidated Statements of Comprehensive Income (Unaudited)

	For the Three Months Ended September 30,						For the Nine Months Ended September 30,
	2014			2013			2014			2013
Net Sales	$	14,569,309		$	14,479,934		$	42,648,515		$	40,859,007
Cost of Sales		10,824,765			11,182,419			32,380,526			32,105,384
Gross profit		3,744,544			3,297,515			10,267,989			8,753,623
Operating expenses:
General and administrative		1,623,858			1,616,263			5,498,835			4,562,322
Selling		1,006,080			553,482			2,333,524			1,448,897
Advertising and marketing		595,622			461,991			1,646,395			1,255,339
Total operating expenses		3,225,560			2,631,736			9,478,754			7,266,558
Income from operations		518,984			665,779			789,235			1,487,065
Other (expense) income:
Interest expense		(241,218	)		(309,372	)		(760,602	)		(988,657	)
Interest income		5,536			5,536			18,452			16,607
Foreign currency gain		8,049			40,641			5,568			14,343
Total other expense, net		(227,633	)		(263,195	)		(736,582	)		(957,707	)
Net income before taxes		291,351			402,584			52,653			529,358
Income tax expense		122,202			162,362			36,299			223,762
Net income		169,149			240,222			16,354			305,596
Less: Net (loss) income attributable to noncontrolling interest		(40,366	)		5,898			(116,096	)		(3,082	)
Net income attributable to CTI Industries Corporation	$	209,515		$	234,324		$	132,450		$	308,678
Other Comprehensive (Loss) Income
Foreign currency adjustment		(363,410	)		(50,338	)		(552,014	)		119,894
Comprehensive (loss) income	$	(153,895	)	$	183,986		$	(419,564	)	$	428,572
Basic income per common share	$	0.06		$	0.07		$	0.04		$	0.10
Diluted income per common share	$	0.06		$	0.07		$	0.04		$	0.09
Weighted average number of shares and equivalent shares of common stock outstanding:
Basic		3,301,116			3,248,646			3,284,023			3,248,646
Diluted		3,450,344			3,401,294			3,436,124			3,404,109

See accompanying notes to condensed consolidated unaudited financial statements

2

CTI Industries Corporation and Subsidiaries

Condensed Consolidated Statements of Cash Flows (Unaudited)

	For the Nine Months Ended September 30,
	2014			2013
Cash flows from operating activities:
Net income	$	16,354		$	305,596
Adjustment to reconcile net income to cash
provided by operating activities:
Depreciation and amortization		1,594,444			1,423,086
Amortization of debt discount		92,253			54,989
Change in value of swap agreement		(59,859	)		(30,942	)
Stock based compensation		60,189			93,632
Provision for losses on accounts receivable		79,943			94,862
Provision for losses on inventories		34,055			71,875
Deferred income taxes		(368,170	)		(41,385	)
Change in assets and liabilities:
Accounts receivable		(2,449,243	)		(1,788,386	)
Inventories		(3,164,333	)		451,467
Prepaid expenses and other assets		412,969			335,209
Trade payables		2,020,513			(505,150	)
Accrued liabilities		(1,119,859	)		(89,353	)
Net cash (used in) provided by operating activities		(2,850,744	)		375,500
Cash used in investing activities - purchases of property, plant and equipment		(838,578	)		(1,476,910	)
Cash flows from financing activities:
Change in checks written in excess of bank balance		338,470			(360,069	)
Net change in revolving line of credit		2,886,194			1,676,487
Proceeds from issuance of long-term debt		75,494			174,959
Repayment of long-term debt (related parties $4,000 and $32,000)		(387,487	)		(374,111	)
Cash paid for deferred financing fees		-			(30,704	)
Purchase of treasury stock		(19,495	)		-
Dividends paid		(16,000	)		-
Proceeds from issuance of stock, net		300,000			-
Net cash provided by financing activities		3,177,176			1,086,562
Effect of exchange rate changes on cash		17,373			(3,726	)
Net decrease in cash and cash equivalents		(494,773	)		(18,574	)
Cash and cash equivalents at beginning of period		666,616			351,064
Cash and cash equivalents at end of period	$	171,843		$	332,490
Supplemental disclosure of cash flow information:
Cash payments for interest	$	861,760		$	863,263
Cash payments for taxes	$	55,466		$	25,000
Supplemental Disclosure of non-cash investing and financing activity
Property, Plant & Equipment acquisitions funded by liabilities	$	102,313		$	86,299

See accompanying notes to condensed consolidated unaudited financial statements

3

CTI Industries Corporation and Subsidiaries

Condensed Consolidated Earnings per Share (unaudited)

	For the Three Months Ended September 30,				For the Nine Months Ended September 30,
	2014		2013		2014		2013
Basic
Average shares outstanding:
Weighted average number of common shares
outstanding		3,301,116		3,248,646		3,284,023		3,248,646
Net income:
Net income attributable to CTI Industries Corporation	$	209,515	$	234,324	$	132,450	$	308,678
Per share amount	$	0.06	$	0.07	$	0.04	$	0.10
Diluted
Average shares outstanding:
Weighted average number of common shares
outstanding		3,301,116		3,248,646		3,284,023		3,248,646
Effect of dilutive shares		149,228		152,648		152,101		155,463
Weighted average number of shares and
equivalent shares of common stock
outstanding		3,450,344		3,401,294		3,436,124		3,404,109
Net income:
Net income attributable to CTI Industries Corporation	$	209,515	$	234,324	$	132,450	$	308,678
Per share amount	$	0.06	$	0.07	$	0.04	$	0.09

See accompanying notes to condensed consolidated unaudited financial statements

4

CTI Industries Corporation and Subsidiaries

Notes to Unaudited Condensed Consolidated Financial Statements

Note 1 - Basis of Presentation

The accompanying condensed (a) consolidated balance sheet as of December 31, 2013, which has been derived from audited consolidated financial statements, and (b) the unaudited interim condensed consolidated financial statements have been prepared and, in the opinion of management, contain all the adjustments (consisting of those of a normal recurring nature) considered necessary to present fairly the consolidated financial position and the consolidated statements of comprehensive income and consolidated cash flows for the periods presented in conformity with generally accepted accounting principles for interim consolidated financial information and the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America. Operating results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2014. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company's annual report on Form 10-K for the fiscal year ended December 31, 2013.

Principles of consolidation and nature of operations:

The condensed consolidated financial statements include the accounts of CTI Industries Corporation and its wholly-owned subsidiaries, CTI Balloons Limited, CTI Helium, Inc. and CTF International S.A. de C.V., its majority-owned subsidiaries CTI Mexico S.A. de C.V., Flexo Universal, S.A. de C.V. and CTI Europe gmbH, as well as the accounts of Venture Leasing S. A. de R. L., Venture Leasing L.L.C and Clever Container Company, L.L.C. (the “Company”). The last three entities have been consolidated as variable interest entities. Clever Container Company, L.L.C. has been consolidated since the beginning of the fourth quarter of 2013. All significant intercompany transactions and accounts have been eliminated in consolidation. The Company (i) designs, manufactures and distributes balloon products throughout the world and (ii) operates systems for the production, lamination, coating and printing of films used for food packaging and other commercial uses and for conversion of films to flexible packaging containers and other products.

Variable Interest Entities (“VIE’s”):

The determination of whether or not to consolidate a variable interest entity under U.S. GAAP requires a significant amount of judgment concerning the degree of control over an entity by its holders of variable interest. To make these judgments, management has conducted an analysis of the relationship of the holders of variable interest to each other, the design of the entity, the expected operations of the entity, which holder of variable interests is most “closely associated” to the entity and which holder of variable interests is the primary beneficiary required to consolidate the entity. Upon the occurrence of certain events, management reviews and reconsiders its previous conclusion regarding the status of an entity as a variable interest entity. There are three entities that have been consolidated as variable interest entities.

5

Use of estimates:

In preparing condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amount of revenue and expenses during the reporting period in the condensed consolidated financial statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include reserves for doubtful accounts, reserves for the lower of cost or market of inventory, reserves for deferred tax assets and recovery value of goodwill.

Earnings per share:

Basic earnings per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during each period.

Diluted earnings per share is computed by dividing the net income by the weighted average number of shares of common stock and equivalents (stock options and warrants), unless anti-dilutive, during each period.

As of September 30, 2014 and 2013, shares to be issued upon the exercise of options and warrants aggregated 368,548 and 358,648, respectively. The number of anti-dilutive shares (not included in the determination of earnings on a diluted basis) for the three months ended September 30, 2014 and 2013, were 199,000 and 189,000, respectively, all of which were represented by options. The number of anti-dilutive shares for the nine months ended September 30, 2014 and 2013, were 199,000 and 80,000, respectively, all of which were represented by options.

Significant Accounting Policies:

The Company’s significant accounting policies are summarized in Note 2 of the Company’s consolidated financial statements for the year ended December 31, 2013. There were no significant changes to these accounting policies during the three and nine months ended September 30, 2014.

Recent Accounting Pronouncements:

In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on the recognition of revenue from contracts with customers. Revenue recognition will depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also requires disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance permits two methods of adoption: retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application. The guidance is effective January 1, 2017 and early adoption is not permitted. The company is currently evaluating the impact of the new guidance and the method of adoption in the consolidated financial results.

In August 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-15, “Presentation of Financial Statements-Going Concern (Topic 205-40)” (“ASU 2014-15”). Under the standard, management is required to evaluate for each annual and interim reporting period whether it is a probable that the entity will not be able to meet its obligations as they become due within one year after the date that financial statements are issued, or are available to be issued, where applicable. ASU 2014-15 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016, and early adoption is permitted. Accordingly, the standard is effective for the Company on January 1, 2017. The Company does not believe that the pronouncement will have an impact on the Company's financial statements.

6

Note 2 - Stock-Based Compensation; Changes in Equity

The Company has adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718 which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the condensed consolidated financial statements based on their grant-date fair values.

The Company has applied the Black-Scholes model to value stock-based awards and issued warrants related to notes payable. That model incorporates various assumptions in the valuation of stock-based awards relating to the risk-free rate of interest to be applied, the estimated dividend yield and expected volatility of our common stock. The risk-free rate of interest is the related U.S. Treasury yield curve for periods within the expected term of the option at the time of grant. The dividend yield on our common stock is estimated to be 0%, as the Company did not issue dividends during 2014 and 2013. The expected volatility is based on historical volatility of the Company’s common stock.

The Company’s net income for the three months ended September 30, 2014 and 2013 includes approximately $17,000 and $24,000, respectively of compensation costs related to share based payments. The Company’s net income for the nine months ended September 30, 2014 and 2013 includes approximately $60,000 and $94,000, respectively of compensation costs related to share based payments. As of September 30, 2014 there is $60,000 of unrecognized compensation expense related to non-vested stock option grants and stock grants. We expect approximately $17,000 of additional stock-based compensation expense to be recognized over the remainder of 2014, $29,000 to be recognized during 2015, $11,000 to be recognized during 2016, and $3,000 to be recognized during 2017.

As of September 30, 2014, the Company had three stock-based compensation plans pursuant to which stock options were, or may be, granted. The Plans provide for the award of options, which may either be incentive stock options (“ISOs”) within the meaning of Section 422A of the Internal Revenue Code of 1986, as amended (the “Code”) or non-qualified options (“NQOs”) which are not subject to special tax treatment under the Code, as well as for stock grants.

On April 12, 2001, the Board of Directors approved for adoption, effective December 27, 2001, the 2001 Stock Option Plan (“2001 Plan”). The 2001 Plan authorizes the grant of options to purchase up to an aggregate of 119,050, shares of the Company’s Common Stock. As of September 30, 2014, options for 139,958 shares (including cancelled shares re-issued under the Plan) have been granted and were fully vested at the time of grant and options for 2,000 shares remain outstanding.

On April 24, 2002, the Board of Directors approved for adoption, effective October 12, 2002, the 2002 Stock Option Plan (“2002 Plan”). The 2002 Plan authorizes the grant of options to purchase up to an aggregate of 142,860 shares of the Company’s Common Stock. As of September 30, 2014, options for 123,430 shares have been granted and were fully vested at the time of grant and options for 27,500 shares remain outstanding.

7

On April 10, 2009, the Board of Directors approved for adoption, and on June 5, 2009, the shareholders of the Corporation approved, a 2009 Stock Incentive Plan (“2009 Plan”). The 2009 Plan authorizes the issuance of up to 250,000 shares of stock or options to purchase stock of the Company. As of September 30, 2014, options for 201,000 shares had been granted and options for 199,000 shares remain outstanding.

A summary of the Company’s stock option activity and related information is as follows:

	Shares under Option		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
Balance at December 31, 2013		228,500	$	5.23		3.0	$	161,250
Granted		-		-
Cancelled		-		-
Exercised		-		-
Outstanding at September 30, 2014		228,500	$	5.23		2.3	$	30,090
Exercisable at September 30, 2014		120,182	$	4.92		2.0	$	30,090

On July 17, 2012, the Company entered into a Note and Warrant Purchase Agreement with BMO Equity pursuant to which (i) BMO Equity advanced to the Company the sum of $5 million and (ii) the Company issued to BMO Equity a warrant to purchase up to Four Percent (4%) of the outstanding shares of common stock of the Company on a fully-diluted basis (140,048 shares of common stock of the Company) at the price of One Cent ($0.01) per share. The term of the loan provided for in this Agreement is five and a half years. Interest is payable on the outstanding balance of the loan at the rate of 11.5% per annum.

On April 12, 2013, the Company entered into Amendment No. 1 to the Note and Warrant Purchase Agreement among the Company and BMO Equity. In the Amendment, non-compliance with financial covenants prior to the date of the Amendment were waived and the Note and Warrant Purchase Agreement was amended (i) to modify the Senior Leverage Ratio and Total Leverage Ratio requirements for the fiscal quarter ending June 30, 2013 and each quarter thereafter during the term of the Note and Warrant Purchase Agreement and (ii) to modify the definitions of EBITDA and Total Funded Debt.

On September 30, 2014, the Company received waivers from each of BMO Harris and BMO Equity for non-compliance with all the financial covenants under the Credit Agreement and the Note and Warrant Purchase Agreement.

Management of the Company is currently engaged in negotiations with BMO Harris and BMO Equity, and in financing efforts, for a long-term restructuring of the agreements with those entities under which financial covenants would be modified, additional financing provided and reduction of certain loan balances achieved. Management believes that a restructuring of these agreements will be completed during the fourth quarter 2014.

8

A summary of the Company’s stock warrant activity and related information is as follows:

	Shares under Warrant		Weighted Average Exercise Price		Weighted Average Remaining Contractual Life		Aggregate Intrinsic Value
Balance at December 31, 2013		140,048	$	0.01		8.5	$	816,480
Granted
Cancelled		-		-
Exercised		-		-
Outstanding at September 30, 2014		140,048	$	0.01		7.8	$	544,787
Exercisable at September 30, 2014		-		-		-		-

A summary of the Company’s stock option activity by grant date as of September 30, 2014 is as follows:

	Options Outstanding								Options Vested
Options by Grant Date	Shares		Weighted Avg.		Remain. Life		Intrinsic Val		Shares		Weighted Avg.		Remain. Life		Intrinsic Val
Dec 2005		29,500	$	2.88		1.3	$	30,090		29,500	$	2.88		1.3	$	30,090
Dec 2010		72,000		6.14		1.3		-		39,750		5.97		1.3		-
Jan 2011		8,000		5.96		1.3		-		5,332		5.96		1.3		-
Nov 2012		109,000		5.17		3.2		-		43,600		5.17		3.2		-
Nov 2013		10,000		5.75		4.1		-		2,000		5.75		4.1		-
TOTAL		228,500	$	5.23		2.3	$	30,090		120,182	$	4.92		2.0	$	30,090

The aggregate intrinsic value in the tables above represents the total pre-tax intrinsic value (the difference between the closing price of the Company’s common stock on the last trading day of the quarter ended September 30, 2014 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all the holders exercised their options on September 30, 2014.

Note 3 - Legal Proceedings

On September 2, 2014, Amada Gonzalez and Leticia Ocampo, individually, and purportedly on behalf of a class of other persons similarly situated, filed and action in the United States District Court for the Northern District of Illinois against the Company, Ron’s Temporary Help Services, Inc., Prime Staffing, Inc. and Extreme Staffing Solution Corp. The individual plaintiffs are alleged to be persons who were employed by one of the temporary staffing companies named as defendants in the action and who worked at the Company’s facilities. The complaint includes claims of alleged violations of The Fair Labor Standards Act, the Illinois Wage Payment and Collection Act, The Illinois Minimum Wage Law and the Illinois Day and Temporary Labor Services Act, for alleged failure to pay minimum wages, overtime wages or vacation pay. Liability is asserted against the Company as an alleged “joint employer.” The complaint requests judgment for the amount of alleged unpaid wages, unspecified liquidated damages, attorney’s fees and injunctive relief. The Company has not yet responded to the complaint but intends vigorously to defend against all of the claims made. An estimate of the possible loss or range of loss with respect to this claim cannot be made.

9

In addition to the foregoing, the Company is party to certain claims or actions arising in the normal course of business. The ultimate outcome of these matters is unknown but, in the opinion of management, the resolution of these matters is not expected to have a significant effect on the future financial position or results of operations of the Company.

Note 4 - Other Comprehensive Income

In the three and nine months ended September 30, 2014 the company had a comprehensive loss of $363,000 and a comprehensive loss of $552,000, respectively, all from foreign currency translation adjustments.

The following table sets forth the accumulated balance of other comprehensive loss and each component.

	Foreign Currency Items			Total Accumulated Other Comprehensive Loss
Beginning balance as of January 1, 2014	$	(2,253,501	)	$	(2,253,501	)
Current period change, net of tax		(552,014	)		(552,014	)
Ending Balance as of September 30, 2014	$	(2,805,515	)	$	(2,805,515	)

Note 5 - Inventories, Net

	September 30, 2014			December 31, 2013
Raw materials	$	3,927,047		$	3,342,528
Work in process		1,653,392			1,149,704
Finished goods		13,591,550			11,673,872
Allowance for excess quantities		(771,483	)		(737,691	)
Total inventories	$	18,400,506		$	15,428,413

Note 6 - Geographic Segment Data

The Company has determined that it operates primarily in one business segment which designs, manufactures and distributes film and film related products for use in packaging, storage and novelty balloon products. The Company operates in foreign and domestic regions. Information about the Company's operations by geographic areas is as follows: 

10

	Net Sales to Outside Customers				Net Sales to Outside Customers
	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
United States	$	10,808,000	$	10,837,000	$	30,986,000	$	30,496,000
Europe		380,000		282,000		1,182,000		709,000
Mexico		2,789,000		2,844,000		8,424,000		8,052,000
United Kingdom		592,000		517,000		2,057,000		1,602,000
	$	14,569,000	$	14,480,000	$	42,649,000	$	40,859,000

	Total Assets at
	September 30,		December 31,
	2014		2013
United States	$	31,930,000	$	28,758,000
Europe		1,370,000		1,145,000
Mexico		8,366,000		8,144,000
United Kingdom		1,399,000		1,025,000
	$	43,065,000	$	39,072,000

Note 7 - Concentration of Credit Risk

Concentration of credit risk with respect to trade accounts receivable is generally limited due to the large number of entities comprising the Company's customer base. The Company performs ongoing credit evaluations and provides an allowance for potential credit losses against the portion of accounts receivable which is estimated to be uncollectible. Such losses have historically been within management's expectations. During the three months ended September 30, 2014 and 2013, there were two and three customers whose purchases represented more than 10% of the Company’s consolidated net sales, respectively. During the nine months ended September 30, 2014 and 2013, there were two customers whose purchases represented more than 10% of the Company’s consolidated net sales, respectively. Sales to these customers for the three and nine months ended September 30, 2014 and 2013 are as follows:

11

	Three Months Ended					Three Months Ended
	September 30, 2014					September 30, 2013
Customer	Net Sales		% of Net Sales			Net Sales		% of Net Sales
Customer A	$	3,369,000		23.1	%	$	3,002,000		20.7	%
Customer B	$	2,420,000		16.6	%	$	1,977,000		13.7	%
Customer C		N/A		N/A		$	1,884,000		13.0	%

	Nine Months Ended					Nine Months Ended
	September 30, 2014					September 30, 2013
Customer	Net Sales		% of Net Sales			Net Sales		% of Net Sales
Customer A	$	11,299,000		26.5	%	$	11,412,000		27.9	%
Customer B	$	5,583,000		13.1	%	$	4,658,000		11.4	%

As of September 30, 2014, the total amounts owed to the Company by these customers were approximately $2,089,000 or 18.8%, and $2,430,000 or 21.9%, of the Company’s consolidated net accounts receivable, respectively. The amounts owed at September 30, 2013 by these customers were approximately $1,286,000 or 13.6%, $1,915,000 or 20.3%, and $1,054,000 or 11.2% of the Company’s consolidated net accounts receivable.

Note 8 - Related Party Transactions

Stephen M. Merrick, President of the Company, is of counsel to the law firm of Vanasco Genelly and Miller PC which provides legal services to the Company. Legal fees paid by the Company to this firm for the three months ended September 30, 2014 and 2013, respectively, were $33,000 and $27,000. Legal fees paid by the Company to this firm for the nine months ended September 30, 2014 and 2013, respectively, were $84,000 and $89,000.

John H. Schwan, Chief Executive Officer of the Company, during a portion of 2013, was a principal of Shamrock Specialty Packaging and affiliated companies. The Company made payments for packaging materials supplied by Shamrock of approximately $487,000 during the three months ended September 30, 2014 and $265,000 during the three months ended September 30, 2013. The Company made payments for packaging materials supplied by Shamrock of approximately $1,506,000 during the nine months ended September 30, 2014 and $1,683,000 during the nine months ended September 30, 2013. At September 30, 2014 and 2013, outstanding accounts payable balances were $110,000 and $138,000, respectively.

John H. Schwan, Chief Executive Officer of the Company, is the brother of Gary Schwan, one of the owners of Schwan Incorporated, which provides building maintenance and remodeling services to the Company. The Company made payments to Schwan Incorporated of approximately $21,000 during the three months ended September 30, 2014 and $1,000 during the three months ended September 30, 2013. The Company made payments to Schwan Incorporated of approximately $21,000 during the nine months ended September 30, 2014 and $15,000 during the nine months ended September 30, 2013.

12

Interest payments have been made or accrued to John H. Schwan for loans made to the Company. During the three months ended September 30, 2014 and 2013 these interest payments totaled $20,000 and $19,000, respectively. During the nine months ended September 30, 2014 and 2013 these interest payments totaled $60,000 and $57,000, respectively.

On July 1, 2011, Flexo Universal, S.A. de C.V. (“Flexo”) entered into a lease agreement with Venture Leasing S.A. de R.L. (“Venture Leasing Mexico”) for the lease of balloon production equipment financed and owned by Venture Leasing Mexico and used by Flexo for the production of latex balloons. Venture Leasing Mexico is wholly owned by entities owned by John H. Schwan, Chief Executive Officer of the Company and Stephen M. Merrick, President of the Company. Venture Leasing Mexico and Venture Leasing L.L.C., also owned by entities owned by Mr. Schwan and Mr. Merrick, are deemed variable interest entities and are consolidated with the accounts of the Company. During the three and nine months ended September 30, 2014, Flexo made lease payments to Venture Leasing Mexico totaling $36,000 and $109,000. During the three and nine months ended September 30, 2013, Flexo made lease payments to Venture Leasing Mexico totaling $36,000 and $109,000.

Note 9 - Derivative Instruments; Fair Value

The following tables represents information about the Company’s assets and liabilities measured at fair value on a recurring basis as of September 30, 2014 and December 30, 2013, and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value:

	Amount as of
Description	9/30/2014		Level 1		Level 2		Level 3
Warrant Liability		545,000		-		545,000
	$	545,000	$	-	$	545,000	$	-

	Amount as of
Description	12/31/2013		Level 1		Level 2		Level 3
Interest Rate Swap	$	60,000	$	-	$	60,000	$	-
Warrant Liability		816,000		-		816,000		-
	$	876,000			$	876,000

The Company is exposed to certain market risks including the effect of changes in interest rates. The Company uses derivative instruments to manage financial exposures that occur in the normal course of business. It does not hold or issue derivatives for speculative trading purposes. The Company is exposed to non-performance risk from the counterparties in its derivative instruments. This risk would be limited to any unrealized gains on current positions. To help mitigate this risk, the Company transacts only with counterparties that are rated as investment grade or higher and all counterparties are monitored on a continuous basis. The fair value of the Company’s derivatives reflects this credit risk.

13

On July 1, 2011, the Company entered into a swap agreement with BMO Capital Markets with respect to $6,780,000 of our loan balances with BMO Harris Bank N.A. This swap agreement limits the Company’s exposure to interest rate fluctuations on the Company’s floating rate loans. The swap agreement has the effect of fixing the interest rate on the loan balances covered by the swap at 4.65% per annum. The swap agreement is a derivative financial instrument and we determine and record the fair market value of the swap agreement each quarter. The value is recorded on the balance sheet of the Company and the amount of the unrealized gain or loss for each period is recorded as interest income or expense. The swap agreement has expired as of September 30, 2014.

Fair Values of Derivative Instruments in the Statement of Financial Position

	Liability Derivatives as of
	September 30, 2014			December 31, 2013
Derivatives not designated as hedging instruments under Statement 133	Balance Sheet Location	Fair Value		Balance Sheet Location	Fair Value
Interest Rate Contracts	Accrued Liabilities	$	-	Accrued Liabilities	$	60,000

The Effect of Derivative Instruments on the Statement of Financial Performance

	For the three months ended
	September 30, 2014			September 30, 2013
Derivatives not Designated as Hedging Instruments under Statement 133	Location of Gain (Loss) Recognized in Income on Derivative	Amount of Gain (Loss) Recognized in Income on Derivative		Location of Gain (Loss) Recognized in Income on Derivative	Amount of Gain (Loss) Recognized in Income on Derivative
Interest Rate Contracts	Interest Expense	$	-	Interest Expense	$	(3,000	)
Interest on fixed/variable rate variances		$	21,000		$	21,000

The Effect of Derivative Instruments on the Statement of Financial Performance  

	For the nine months ended
	September 30, 2014			September 30, 2013
Derivatives not Designated as Hedging Instruments under Statement 133	Location of Gain (Loss) Recognized in Income on Derivative	Amount of Gain (Loss) Recognized in Income on Derivative		Location of Gain (Loss) Recognized in Income on Derivative	Amount of Gain (Loss) Recognized in Income on Derivative
Interest Rate Contracts	Interest Expense	$	3,000	Interest Expense	$	(12,000	)
Interest on fixed/variable rate variances		$	63,000		$	61,000

14

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward Looking Statements

This quarterly report includes both historical and “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. We have based these forward-looking statements on our current expectations and projections about future results. Words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar words are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Although we believe that our opinions and expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements, and our actual results may differ substantially from the views and expectations set forth in this quarterly report on Form 10-Q. We disclaim any intent or obligation to update any forward-looking statements after the date of this quarterly report to conform such statements to actual results or to changes in our opinions or expectations.

Overview

We produce film products for novelty, packaging and container applications. These products include foil balloons, latex balloons and related latex toy products, films for packaging and custom product applications, and flexible containers for packaging and consumer storage applications. We produce all of our film products for packaging, container applications and foil balloons at our plant in Lake Barrington, Illinois. We produce all of our latex balloons and latex products at our facility in Guadalajara, Mexico. Substantially all of our film products for packaging and custom product applications are sold to customers in the United States. We market and sell our novelty items and flexible containers for consumer use in the United States, Mexico, Latin America, and Europe. We also market and sell vacuum sealing machines which we purchase from a supplier.

Results of Operations

Net Sales. For the three months ended September 30, 2014, net sales were $14,569,000 compared to net sales of $14,480,000 for the same period of 2013, an increase of 0.6%. For the quarters ended September 30, 2014 and 2013, net sales by product category were as follows:

	Three Months Ended
	September 30, 2014		September 30, 2013
	$	% of	$	% of
Product Category	(000) Omitted	Net Sales	(000) Omitted	Net Sales
Foil Balloons	5,657	39%	4,679	32%
Latex Balloons	3,001	20%	3,178	22%
Vacuum Sealing Products	3,777	26%	3,585	25%
Film Products	1,435	10%	1,919	13%
Other Sales	699	5%	1,119	8%
Total	14,569	100%	14,480	100%

15

For the nine months ended September 30, 2014, net sales were $42,649,000 compared to net sales of $40,859,000 for the same period of 2013, an increase of 4.4%. For the nine months ended September 30, 2014 and 2013, net sales by product category were as follows:

	Nine Months Ended
	September 30, 2014		September 30, 2013
	$	% of	$	% of
Product Category	(000) Omitted	Net Sales	(000) Omitted	Net Sales
Foil Balloons	19,045	45%	17,021	42%
Latex Balloons	8,986	21%	9,174	22%
Vacuum Sealing Products	8,599	20%	8,606	21%
Film Products	3,364	8%	4,103	10%
Other Sales	2,655	6%	1,955	5%
Total	42,649	100%	40,859	100%

Foil Balloons. During the three months ended September 30, 2014 revenues from the sale of foil balloons increased by 20.9% compared to the prior year period from $4,679,000 to $5,657,000. During the nine months ended September 30, 2014 revenues from the sale of foil balloons increased by 11.9% compared to the prior year period from $17,021,000 to $19,045,000. During the nine months ended September 30, 2014, foil balloon sales to our largest customer increased to $10,982,000 from $10,613,000 in the nine months ended 2013. Sales of foil balloons to other customers increased to $8,063,000 from $6,408,000 for the same period last year. These included sales to various customers in the United States, Mexico, the United Kingdom and Europe, including increases in sales to existing customers and new customers in each of those markets. Most of the increased sales constitute sales to four chain stores in the U.S., the United Kingdom and Germany.

Latex Balloons. During the three months ended September 30, 2014 revenues from the sale of latex balloons decreased by 5.6% compared to the prior year period from $3,178,000 to $3,001,000. During the nine months ended September 30, 2014 revenues from the sale of latex balloons decreased by 2.0% compared to the prior year period from $9,174,000 to $8,986,000. The decrease during the nine months ended September 30, 2014 was attributable to decreased sales of latex to a principal customer in the U.S. to $317,000 from $799,000 in the nine months ended 2013.

16

Vacuum Sealing Products. During the three months ended September 30, 2014 revenues from the sale of pouches and vacuum sealing machines increased by 5.4% compared to the prior year from $3,585,000 to $3,777,000. During the nine months ended September 30, 2014 revenues from the sale of pouches and vacuum sealing machines decreased slightly by 0.1% compared to the prior year from $8,606,000 to $8,599,000. Our sales in this product line in 2014 and 2013 have been in two product categories: (i) zippered pouches and (ii) vacuum sealing systems incorporating vacuum sealing machines and associated pouches and rolls of film. For the three and nine months ended 2014 and 2013, sales of pouch products (and vacuum sealing machines) in these categories have been as follows:

	Three Months Ended September 30,				Nine Months Ended September 30,
	2014		2013		2014		2013
Zippered Pouches	$	734,000	$	628,000	$	1,915,000	$	2,152,000
Vacuum Sealing Systems		3,043,000		2,957,000		6,684,000		6,454,000
Total	$	3,777,000	$	3,585,000	$	8,599,000	$	8,606,000

Zippered Pouches. Most of our sales of zippered pouches have been of branded products to a principal customer, although we have had limited sales of our ZipVac® pouch line as well. Sales of the zippered pouch products declined during the nine months ended September 30, 2014 from $2.2 million in the first nine months of 2013 to $1.9 million during the same period in 2014.

Vacuum Sealing Systems. Since 2012, we have offered a line of vacuum sealing systems which include vacuum sealing machines and associated pouches and rolls of film.

In December, 2011, we entered into a Trademark License Agreement with S. C. Johnson & Son, Inc. pursuant to which we received a license to market and sell vacuum sealing machines as well as pouches and rolls of film for use with those machines, under the Ziploc brand name. In the first quarter 2012, we introduced and began to market and sell that branded line of vacuum sealing machines and associated open-top bags and rolls. Since that time, we have offered our branded vacuum sealing system lines of product principally to chain stores in the United States, including several major chains.

Our sales of our branded vacuum sealing systems increased from $6.5 million during the nine months ended September 30, 2013 to $6.7 million during the same period this year, principally as the result of sales to several of retail chain stores.

Films. During the three months ended September 30, 2014 revenues from the sale of laminated film products decreased by 25.2% compared to the prior year period from $1,919,000 to $1,435,000. During the nine months ended September 30, 2014 revenues from the sale of laminated film products decreased by 18% compared to the prior year period from $4,103,000 to $3,364,000. The decrease is attributable to a decrease in sales to a principal customer. Approximately 98.5% of the sales of laminated film products during the nine months ended September 30, 2014 were to a principal customer.

Other Revenues. During the three months ended September 30, 2014, we had revenues from the sale of various other products totaling $699,000 compared to revenues from other products in the same period during 2013 of $1,119,000. During the nine months ended September 30, 2014, we had revenues from the sale of various other products totaling $2,655,000 compared to revenues from other products in the same period during 2013 of $1,955,000. The revenues from the sale of such other products during 2014 include (i) sales of home container products by a variable interest entity which we now consolidate with our financial results in the amount of $1,612,000, (ii) sales of a line of “Candy Blossoms” and “Candy Loons” consisting of candy and small inflated balloons sold in small containers, and (iii) the sale of accessories and supply items related to balloon products.

17

Sales to a limited number of customers continue to represent a large percentage of our net sales. The table below illustrates the impact on sales of our top three and ten customers for the three and nine months ended September 30, 2014 and 2013.

	Three Months Ended September 30,		Nine Months Ended September 30,
	% of Sales		% of Sales
	2014	2013	2014	2013
Top 3 Customers	49.4%	47.4%	47.4%	49.2%
Top 10 Customers	70.8%	72.4%	65.4%	69.9%

During the three months ended September 30, 2014, there were two customers whose purchases represented more than 10% of the Company’s consolidated net sales. Sales to these customers for the three months ended September 30, 2014 were $3,369,000 or 23.1%, and $2,420,000 or 16.6%, of consolidated net sales, respectively. Sales to the top customers for the three months ended September 30, 2013, were $3,002,000 or 20.7%, 1,977,000 or 13.7%, and $1,884,000 or 13.0% of consolidated net sales. During the nine months ended September 30, 2014, there were two customers whose purchases represented more than 10% of the Company’s consolidated net sales. Sales to these customers for the nine months ended September 30, 2014 were $11,299,000 or 26.5% and $5,583,000 or 13.1%, of consolidated net sales, respectively. Sales to these customers for the nine months ended September 30, 2013 were $11,412,000 or 27.9% and $4,658,000 or 11.4% of consolidated net sales, respectively. As of September 30, 2014, the total amounts owed to the Company by the top three customers were $2,089,000 or 18.8%, and $2,430,000 or 21.9%, of the Company’s consolidated net accounts receivable, respectively. The amount owed at September 30, 2013 by the top three customers were $1,286,000 or 13.6%, $1,915,000 or 20.3% and $1,054,000 or 11.2%, of the Company’s consolidated net accounts receivable, respectively.

Cost of Sales. During the three months ended September 30, 2014, the cost of sales represented 74.3% of net sales compared to 77.2% for the three months ended September 30, 2013. During the nine months ended September 30, 2014, the cost of sales represented 75.9% of net sales compared to 78.6% for the nine months ended September 30, 2013. The improvement in gross margins is attributable principally to (i) sales by our Company, and the variable interest entity now consolidated with our financial results, of products having a greater gross margin rate than other products, and (ii) an increase in the gross margins at our Mexico subsidiary. The improvement in gross margins at our Mexico subsidiary is attributable principally to (i) a decline in the price of natural latex, (ii) an increase in sales of higher margin products, and (iii) improvement in manufacturing efficiencies.

General and Administrative. During the three months ended September 30, 2014, general and administrative expenses were $1,624,000 or 11.1% of net sales, compared to $1,616,000 or 11.2% of net sales for the same period in 2013. During the nine months ended September 30, 2014, general and administrative expenses were $5,499,000 or 12.9% of net sales, compared to $4,562,000 or 11.2% of net sales for the same period in 2013. The increase in general and administrative expenses is attributable principally to (i) administrative expenses of $415,000 of a variable interest entity which was consolidated with our financial statements beginning in the fourth quarter of 2013, (ii) an increase in administrative expenses at our Mexico subsidiary of $103,000, (iii) an increase in audit expenses of $64,000 (iv) an increase in outside services of $65,000, (v) an increase in corporate fees of $41,000 (vi) an increase in bad debt expense of $24,000 and (vii) an increase in depreciation relating to the vacuum sealing product line.

18

Selling. During the three months ended September 30, 2014, selling expenses were $1,006,000 or 6.9% of net sales, compared to $553,000 or 3.8% of net sales for the same period in 2013. During the nine months ended September 30, 2014, selling expenses were $2,334,000 or 5.5% of net sales, compared to $1,449,000 or 3.5% of net sales for the same period in 2013. The increase in selling expenses is attributable principally to (i) an increase in royalty expenses of $220,000, (ii) selling expenses of a variable interest entity consolidated with our financial statements in the amount of $564,000, and (iii) an increase in commission expense of 102,000.

Advertising and Marketing. During the three months ended September 30, 2014, advertising and marketing expenses were $596,000 or 4.1% of net sales for the period, compared to $462,000 or 3.2% of net sales for the same period of 2013. During the nine months ended September 30, 2014, advertising and marketing expenses were $1,646,000 or 3.9% of net sales for the period, compared to $1,255,000 or 3.1% of net sales for the same period of 2013. The increase in advertising and marketing expense is attributable to (i) outside services of $309,000, (ii) an increase in advertising related to the vacuum sealer machines of $98,000, and (iii) advertising expenses of a variable interest entity consolidated with our financial statements in the amount of $55,000.

Other Income (Expense). During the three months ended September 30, 2014, the Company incurred net interest expense of $236,000, compared to net interest expense during the same period of 2013 in the amount of $304,000. During the nine months ended September 30, 2014, the Company incurred net interest expense of $742,000, compared to net interest expense during the same period of 2013 in the amount of $972,000. The decrease in interest expense for the nine months ended September 30, 2014 is attributable to a reduction in the amount of amortized debt discount we were required to recognize in relation to our mezzanine loan financing.

For the three months ended September 30, 2014, the Company had a foreign currency transaction gain of $8,000 compared to a foreign currency transaction gain of $41,000 during the same period of 2013. For the nine months ended September 30, 2014, the Company had a foreign currency transaction gain of $6,000 compared to a foreign currency transaction gain of $14,000 during the same period of 2013.

Income Taxes. For the three months ended September 30, 2014, the Company reported a consolidated income tax expense of $122,000, compared to a consolidated income tax expense of $162,000 for the same period of 2013. For the nine months ended September 30, 2014, the Company reported a consolidated income tax expense of $36,000, compared to a consolidated income tax expense of $224,000 for the same period of 2013. For the nine months ended September 30, 2014, this income tax expense was composed of an income tax benefit in the United States, income tax expense in Mexico of Flexo Universal, our Mexican subsidiary, income tax benefit in the United Kingdom of CTI Balloons Limited, our United Kingdom subsidiary and income tax expense in Europe of CTI Europe gmbH, our Germany subsidiary.

Net Income. For the three months ended September 30, 2014, the Company had net income of $210,000 or $0.06 per share (basic and diluted), compared to net income of $234,000 for the same period of 2013 or $0.07 per share (basic and diluted). For the nine months ended September 30, 2014, the Company had net income of $132,000 or $0.04 per share (basic and diluted), compared to net income of $309,000 ($0.10 per share basic and $0.09 per share diluted) for the same period of 2013. For the nine months ended September 30 2014, the Company had income from operations of $789,000 compared to income from operations during the same period in 2013 of $1,487,000.

19

Financial Condition, Liquidity and Capital Resources

Cash Flow Items.

Operating Activities. During the nine months ended September 30, 2014, net cash used in operations was $2,851,000, compared to net cash provided by operations during the nine months ended September 30, 2013 of $376,000.

Significant changes in working capital items during the nine months ended September 30, 2014 consisted of (i) an increase in accounts receivable of $2,449,000, (ii) an increase in inventories of $3,164,000, (iii) depreciation and amortization in the amount of $1,594,000, (iv) an increase in trade payables of $2,021,000, and (v) a decrease in prepaid expenses and other assets of $413,000. The increase in inventory was attributable principally to an increase in inventory related to our vacuum sealing product line and an increase in raw materials at our Mexico subsidiary. The increase in accounts receivable was attributable principally to an increase in accounts receivable to a certain customer in the United States and a change in terms with a customer in Mexico.

Investing Activity. During the nine months ended September 30, 2014, cash used in investing activity was $839,000, compared to $1,477,000 in the same period of 2013. Substantially all of this expense is related to equipment acquisitions and capitalized maintenance, leasehold improvements, tooling and related expense.

Financing Activities. During the nine months ended September 30, 2014, cash provided by financing activities was $3,177,000 compared to cash provided by financing activities for the same period of 2013 in the amount of $1,087,000. During the nine months ended September 30, 2014, financing activities included payment of $387,000 on long-term debt obligations, proceeds from issuance of stock of $300,000, and an increase in the amount outstanding under our revolving line of credit of $2,886,000.

Liquidity and Capital Resources. At September 30, 2014, the Company had cash balances of $172,000 compared to cash balances of $332,000 for the same period in 2013 and there was $731,000 available to advance under the Company’s revolving line of credit.

At September 30, 2014, the Company had a working capital balance of $11,285,000 compared to a working capital balance of $11,738,000 at December 31, 2013.

The Company’s liquidity is dependent significantly on its bank financing and the Company relies on its revolving line of credit to maintain liquidity. On April 29, 2010, the Company entered into a Credit Agreement with BMO Harris Bank N.A. (“BMO Harris”). Under the Credit Agreement, BMO Harris agreed to provide loans and credits to the Company in the aggregate maximum amount of $14,417,000. The arrangement included:

i. A revolving credit line up to a maximum amount of $9,000,000 based upon a borrowing base of 85% of eligible receivables and 60% of eligible inventory (up to a maximum of $5,000,000);

ii. A mortgage loan in the principal amount of $2,333,350, amortized over 25 years;

iii. A term loan in the principal amount of $583,333 maturing in monthly principal installments of $58,333; and

iv. An equipment loan commitment in the amount of up to $2,500,000 providing for loan advances from time to time until April 29, 2012 based upon 100% of the purchase price of equipment purchased, the loans to be amortized on a five year basis commencing April 29, 2012.

20

The Credit Agreement included various representations, warranties and covenants of the Company, including various financial covenants.

In connection with the Credit Agreement, the Company executed and delivered to BMO Harris, a Term Loan Note, a Mortgage Loan Note, an Equipment Note and a Revolving Note, as well as a form of Mortgage, Security Agreement, Pledge Agreement (pursuant to which shares of capital stock of the Registrant’s Mexico subsidiary were pledged as security for the loans), Patent Security Agreement and Trademark Security Agreement. Two officers and principal shareholders of the Company, John H. Schwan and Stephen M. Merrick each executed Limited Guaranties of the loans and also executed Subordination Agreements with respect to obligations of the Company to them.

The Credit Agreement, as amended, provides that the outstanding balance of all loans under the agreement will bear interest with reference to a base rate or, at the option of the Company, with reference to an adjusted LIBOR. At September 30, 2014, the effective rate on the outstanding loan balances was 4.0%.

As of September 30, 2014, the outstanding balances on the loans with BMO Harris were: (i) revolving line of credit, $11,157,000, (ii) mortgage loan, $1,921,000, and (iii) equipment loan, $670,000.

On July 1, 2011, we entered into a swap agreement with BMO Capital Markets with respect to $6,780,000 of our loan balances with BMO Harris. This swap agreement is designated as a cash flow hedge to hedge the Company’s exposure to interest rate fluctuations on the Company’s floating rate loans. The swap agreement has the effect of fixing the interest rate on the loan balances covered by the swap at 4.65% per annum. The swap agreement is a derivative financial instrument and we will determine and record the fair market value of the swap agreement each quarter. This value will be recorded on the balance sheet of the Company and the amount of the unrealized gain or loss for each period will be recorded as interest income or expense.

On July 17, 2012, the Company entered into Amendment Number 3 to the Credit Agreement among the Company and BMO Harris pursuant to which (i) the amount of the loan commitment on the revolver loan of BMO Harris was increased from $9 million to $12 million, (ii) BMO Harris consented to a transaction among the Company and BMO Private Equity (U.S.), Inc. (“BMO Equity”) and (iii) the term of credit and loans to the Company provided in the Credit Agreement and BMO Harris was extended to July 17, 2017.

Also, on July 17, 2012, the Company entered into a Note and Warrant Purchase Agreement with BMO Equity pursuant to which (i) BMO Equity advanced to the Company the sum of $5 million and (ii) the Company issued to BMO Equity a warrant to purchase up to Four Percent (4%) of the outstanding shares of common stock of the Company on a fully-diluted basis (140,048 shares of common stock of the Company) at the price of One Cent ($0.01) per share. The term of the loan provided for in this Agreement is five and a half years. Interest is payable on the outstanding balance of the loan at the rate of 11.5% per annum.

21

The Note and Warrant Purchase Agreement included provisions for:

(i) a closing fee of $100,000

(ii) payment of the principal amount in five and a half years with optional prepayment subject to certain prepayment premiums;

(iii) security for the note obligations in all assets of the Company junior to the security interest of BMO Harris;

(iv) various representations and warranties and covenants of the Company;

(v) financial covenants including an applicable senior leverage ratio, fixed charge coverage ratio and tangible net worth amount.

On April 12, 2013, the Company entered into Amendment No. 4 to the Credit Agreement among the Company and BMO Harris, and Amendment No. 1 to the Note and Warrant Purchase Agreement among the Company and BMO Equity. In the Amendments, non-compliance with financial covenants prior to the date of the Amendments was waived and both the Credit Agreement and the Note and Warrant Purchase Agreement were amended (i) to modify the Senior Leverage Ratio and Total Leverage Ratio requirements for the fiscal quarter ending June 30, 2013 and each quarter thereafter during the term of the Credit Agreement and the Note and Warrant Purchase Agreement and (ii) to modify the definitions of EBITDA and Total Funded Debt in the Credit Agreement and the Note and Warrant Purchase Agreement.

On September 30, 2014, the Company received waivers from each of BMO Harris and BMO Equity for non-compliance with all the financial covenants under the Credit Agreement and the Note and Warrant Purchase Agreement.

Management of the Company is currently engaged in negotiations with BMO Harris and BMO Equity, and in financing efforts, for a long-term restructuring of the agreements with those entities under which financial covenants would be modified, additional financing provided and reduction of certain loan balances achieved. Management believes that a restructuring of these agreements will be completed during the fourth quarter 2014.

Seasonality

In recent years, sales in the foil balloon product line have historically been seasonal with approximately 40% occurring in the period from December through March and 24% being generated in the period from July through October. The sales of latex balloons and laminated film products have not historically been seasonal.

22

Critical Accounting Policies

Please see pages 25-28 of our Annual Report on Form 10-K for the year ended December 31, 2013 for a description of policies that are critical to our business operations and the understanding of our results of operations. The impact and any associated risks related to these policies on our business operations is discussed throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations where such policies affect our reported and expected financial results. No material changes to such information have occurred during the three and nine months ended September 30, 2014.

Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk

Not applicable.

Item 4. Controls and Procedures

Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has reviewed and evaluated the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2014. Based on such review and evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that the disclosure controls and procedures were effective as of September 30, 2014, to ensure that the information required to be disclosed by us in the reports that we file or submit under the Securities Exchange Act of 1934, as amended, (a) is recorded, processed, summarized and reported within the time period specified in the SEC’s rules and forms and (b) is accumulated and communicated to our management, including the officers, as appropriate to allow timely decisions regarding required disclosure. There were no material changes in our internal control over financial reporting during the nine months ended September 30, 2014 that have materially affected or are reasonably likely to materially affect our internal controls over financial reporting.

Part II. OTHER INFORMATION

Item 1. Legal Proceedings

On September 2, 2014, Amada Gonzalez and Leticia Ocampo, individually, and purportedly on behalf of a class of other persons similarly situated, filed and action in the United States District Court for the Northern District of Illinois against the Company, Ron’s Temporary Help Services, Inc., Prime Staffing, Inc. and Extreme Staffing Solution Corp. The individual plaintiffs are alleged to be persons who were employed by one of the temporary staffing companies named as defendants in the action and who worked at the Company’s facilities. The complaint includes claims of alleged violations of The Fair Labor Standards Act, the Illinois Wage Payment and Collection Act, The Illinois Minimum Wage Law and the Illinois Day and Temporary Labor Services Act, for alleged failure to pay minimum wages, overtime wages or vacation pay. Liability is asserted against the Company as an alleged “joint employer.” The complaint requests judgment for the amount of alleged unpaid wages, unspecified liquidated damages, attorney’s fees and injunctive relief. The Company has not yet responded to the complaint but intends vigorously to defend against all of the claims made. An estimate of the possible loss or range of loss with respect to this claim cannot be made.

In addition to the foregoing, the Company is party to certain claims or actions arising in the normal course of business. The ultimate outcome of these matters is unknown but, in the opinion of management, the resolution of these matters is not expected to have a significant effect on the future financial position or results of operations of the Company.

23

Item 1A. Risk Factors

Not applicable.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Not applicable.

Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Submission of Matters to a Vote of Security Holders

Not applicable.

Item 5. Other Information

The Certifications of the Chief Executive Officer and the Chief Financial Officer of the Company Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 are attached as Exhibits to this Report on Form 10-Q.

Item 6. Exhibits

The following are being filed as exhibits to this report:

Exhibit Number	Description
3.1	Third Restated Certificate of Incorporation of CTI Industries Corporation (incorporated by reference to Exhibit A contained in Registrant’s Schedule 14A Definitive Proxy Statement for solicitation of written consent of shareholders, as filed with Commission on October 25, 1999).
3.2	By-laws of CTI Industries Corporation (incorporated by reference to Exhibit 3.1 contained in Registrant’s Form SB-2 Registration Statement (File No. 333-31969) effective November 5, 1997).
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).
32	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
101	Interactive Data Files, including the following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, formatted in XBRL: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statements of Cash Flows, and (iv) the Notes to Consolidated Financial Statements.

24

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated: November 14, 2014	CTI INDUSTRIES CORPORATION
	By:	/s/ John H. Schwan
		John H. Schwan
		Chief Executive Officer
	By:	/s/ Stephen M. Merrick
		Stephen M. Merrick
		President
	By:	/s/ Timothy S. Patterson
		Timothy S. Patterson
		Chief Financial Officer
		Senior Vice President Finance

25

Exhibit Index

Exhibit Number	Description
3.1	Third Restated Certificate of Incorporation of CTI Industries Corporation (incorporated by reference to Exhibit A contained in Registrant’s Schedule 14A Definitive Proxy Statement for solicitation of written consent of shareholders, as filed with Commission on October 25, 1999).
3.2	By-laws of CTI Industries Corporation (incorporated by reference to Exhibit 3.1 contained in Registrant’s Form SB-2 Registration Statement (File No. 333-31969) effective November 5, 1997).
31.1	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).
31.2	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and rule 15d-14(a) of the Securities Exchange Act, as amended (filed herewith).
32	Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith).
101	Interactive Data Files, including the following materials from the Company’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2014, formatted in XBRL: (i) the Consolidated Balance Sheets, (ii) the Consolidated Statements of Income, (iii) the Consolidated Statements of Cash Flows, and (iv) the Notes to Consolidated Financial Statements.

26

EX-31.1

EXHIBIT 31.1

CERTIFICATIONS

I, John H. Schwan, certify that:

1. I have reviewed this quarterly report on Form 10-Q of CTI Industries Corporation.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the condensed consolidated financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 14, 2014
	/s/ John H. Schwan
	John H. Schwan,
	Chief Executive Officer

EX-31.2

EXHIBIT 31.2

CERTIFICATIONS

I, Timothy S. Patterson, certify that:

1. I have reviewed this quarterly report on Form 10-Q of CTI Industries Corporation.

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of the condensed consolidated financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 14, 2014
	By:	/s/ Timothy S. Patterson
		Timothy S. Patterson
		Chief Financial Officer
		Senior Vice President Finance

EX-32

EXHIBIT 32

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report on Form 10-Q of CTI Industries Corporation (the “Company”) for the quarterly period ended September 30, 2014, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), John H. Schwan, as Chief Executive Officer of the Company, and Timothy S. Patterson, as Senior Vice President Finance and Chief Financial Officer of the Company, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:

(1)           The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)           The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ John H. Schwan

John H. Schwan

Chief Executive Officer

Date: November 14, 2014

/s/ Timothy S. Patterson

Timothy S. Patterson

Chief Financial Officer

Senior Vice President Finance

Date: November 14, 2014

The foregoing certification is being furnished solely pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, and is not being “filed” as part of the Form 10-Q or as a separate disclosure document for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to liability under that section. This certification shall not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act except to the extent that this Exhibit 32 is expressly and specifically incorporated by reference in any such filing.

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

XML

Concentration of Credit Risk (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Accounts Receivable	$ 11,114,047		$ 11,114,047		$ 8,883,106
Concentration Risk, Percentage	10.00%	10.00%	10.00%	10.00%
Customer A [Member]
Accounts Receivable	2,089,000	1,286,000	2,089,000	1,286,000
Customer A [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage			18.80%	13.60%
Customer B [Member]
Accounts Receivable	2,430,000	1,915,000	2,430,000	1,915,000
Customer B [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage			21.90%	20.30%
Customer C [Member]
Accounts Receivable		1,054,000		1,054,000
Concentration Risk, Percentage	0.00%	13.00%
Customer C [Member] | Accounts Receivable [Member]
Concentration Risk, Percentage				11.20%

XML

Stock-Based Compensation; Changes in Equity (Details 1) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Outstanding (in shares)	228,500
Shares, Exercisable (in shares)	120,182
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 5.23
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 4.92
Weighted Average Remaining Contractual Life, Outstanding (in years)	2 years 3 months 18 days	8 years 6 months
Weighted Average Remaining Contractual Life, Exercisable (in years)	2 years
Aggregate Intrinsic Value Outstanding (in dollars)	$ 30,090
Aggregate Intrinsic Value, Exercisable (in dollars)	30,090
Warrant [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Balance (in shares)	140,048
Shares, Granted (in shares)
Shares, Cancelled (in shares)	0
Shares, Exercised (in shares)	0
Shares, Outstanding (in shares)	140,048
Shares, Exercisable (in shares)	0
Weighted Average Exercise Price, Balance (in dollars per share)	$ 0.01
Weighted Average Exercise Price, Granted (in dollars per share)
Weighted Average Exercise Price, Cancelled (in dollars per share)	$ 0
Weighted Average Exercise Price, Exercised (in dollars per share)	$ 0
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 0.01
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 0
Weighted Average Remaining Contractual Life, Outstanding (in years)	7 years 9 months 18 days
Weighted Average Remaining Contractual Life, Exercisable (in years)	0 years
Aggregate Intrinsic Value Outstanding (in dollars)	816,480
Aggregate Intrinsic Value Outstanding (in dollars)	544,787
Aggregate Intrinsic Value, Exercisable (in dollars)	$ 0

XML

Derivative Instruments; Fair Value (Details 2) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Derivative Instruments, Gain (Loss) [Line Items]
Derivatives not Designated as Hedging Instruments under Statement 133	Interest Rate Contracts		Interest Rate Contracts
Location of Gain (Loss) Recognized in Income on Derivative	Interest Expense	Interest Expense	Interest Expense	Interest Expense
Amount of Gain (Loss) Recognized in Income on Derivative	$ 0	$ (3,000)	$ 3,000	$ (12,000)
Interest on fixed/variable rate variances	$ 21,000	$ 21,000	$ 63,000	$ 61,000

XML

Stock-Based Compensation; Changes in Equity

9 Months Ended

Sep. 30, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Note 2 - Stock-Based Compensation; Changes in Equity

The Company has adopted Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718 which requires all share-based payments to employees, including grants of employee stock options, to be recognized in the condensed consolidated financial statements based on their grant-date fair values.

The Company has applied the Black-Scholes model to value stock-based awards and issued warrants related to notes payable. That model incorporates various assumptions in the valuation of stock-based awards relating to the risk-free rate of interest to be applied, the estimated dividend yield and expected volatility of our common stock. The risk-free rate of interest is the related U.S. Treasury yield curve for periods within the expected term of the option at the time of grant. The dividend yield on our common stock is estimated to be 0%, as the Company did not issue dividends during 2014 and 2013. The expected volatility is based on historical volatility of the Company’s common stock.

The Company’s net income for the three months ended September 30, 2014 and 2013 includes approximately $17,000 and $24,000, respectively of compensation costs related to share based payments. The Company’s net income for the nine months ended September 30, 2014 and 2013 includes approximately $60,000 and $94,000, respectively of compensation costs related to share based payments. As of September 30, 2014 there is $60,000 of unrecognized compensation expense related to non-vested stock option grants and stock grants. We expect approximately $17,000 of additional stock-based compensation expense to be recognized over the remainder of 2014, $29,000 to be recognized during 2015, $11,000 to be recognized during 2016, and $3,000 to be recognized during 2017.

As of September 30, 2014, the Company had three stock-based compensation plans pursuant to which stock options were, or may be, granted. The Plans provide for the award of options, which may either be incentive stock options (“ISOs”) within the meaning of Section 422A of the Internal Revenue Code of 1986, as amended (the “Code”) or non-qualified options (“NQOs”) which are not subject to special tax treatment under the Code, as well as for stock grants.

On April 12, 2001, the Board of Directors approved for adoption, effective December 27, 2001, the 2001 Stock Option Plan (“2001 Plan”). The 2001 Plan authorizes the grant of options to purchase up to an aggregate of 119,050, shares of the Company’s Common Stock. As of September 30, 2014, options for 139,958 shares (including cancelled shares re-issued under the Plan) have been granted and were fully vested at the time of grant and options for 2,000 shares remain outstanding.

On April 24, 2002, the Board of Directors approved for adoption, effective October 12, 2002, the 2002 Stock Option Plan (“2002 Plan”). The 2002 Plan authorizes the grant of options to purchase up to an aggregate of 142,860 shares of the Company’s Common Stock. As of September 30, 2014, options for 123,430 shares have been granted and were fully vested at the time of grant and options for 27,500 shares remain outstanding.

On April 10, 2009, the Board of Directors approved for adoption, and on June 5, 2009, the shareholders of the Corporation approved, a 2009 Stock Incentive Plan (“2009 Plan”). The 2009 Plan authorizes the issuance of up to 250,000 shares of stock or options to purchase stock of the Company. As of September 30, 2014, options for 201,000 shares had been granted and options for 199,000 shares remain outstanding.

A summary of the Company’s stock option activity and related information is as follows:

		Weighted		Weighted
	Shares	Average		Average	Aggregate
	under	Exercise		Remaining Contractual	Intrinsic
	Option	Price		Life	Value
Balance at December 31, 2013	228,500	$	5.23	3.0	$	161,250
Granted	-		-
Cancelled	-		-
Exercised	-		-
Outstanding at September 30, 2014	228,500	$	5.23	2.3	$	30,090
Exercisable at September 30, 2014	120,182	$	4.92	2.0	$	30,090

On July 17, 2012, the Company entered into a Note and Warrant Purchase Agreement with BMO Equity pursuant to which (i) BMO Equity advanced to the Company the sum of $5 million and (ii) the Company issued to BMO Equity a warrant to purchase up to Four Percent (4%) of the outstanding shares of common stock of the Company on a fully-diluted basis (140,048 shares of common stock of the Company) at the price of One Cent ($0.01) per share. The term of the loan provided for in this Agreement is five and a half years. Interest is payable on the outstanding balance of the loan at the rate of 11.5% per annum.

On April 12, 2013, the Company entered into Amendment No. 1 to the Note and Warrant Purchase Agreement among the Company and BMO Equity. In the Amendment, non-compliance with financial covenants prior to the date of the Amendment were waived and the Note and Warrant Purchase Agreement was amended (i) to modify the Senior Leverage Ratio and Total Leverage Ratio requirements for the fiscal quarter ending June 30, 2013 and each quarter thereafter during the term of the Note and Warrant Purchase Agreement and (ii) to modify the definitions of EBITDA and Total Funded Debt.

On September 30, 2014, the Company received waivers from each of BMO Harris and BMO Equity for non-compliance with all the financial covenants under the Credit Agreement and the Note and Warrant Purchase Agreement.

Management of the Company is currently engaged in negotiations with BMO Harris and BMO Equity, and in financing efforts, for a long-term restructuring of the agreements with those entities under which financial covenants would be modified, additional financing provided and reduction of certain loan balances achieved. Management believes that a restructuring of these agreements will be completed during the fourth quarter 2014.

A summary of the Company’s stock warrant activity and related information is as follows:

		Weighted		Weighted
	Shares	Average		Average	Aggregate
	under	Exercise		Remaining Contractual	Intrinsic
	Warrant	Price		Life	Value
Balance at December 31, 2013	140,048	$	0.01	8.5	$	816,480
Granted
Cancelled	-		-
Exercised	-		-
Outstanding at September 30, 2014	140,048	$	0.01	7.8	$	544,787
Exercisable at September 30, 2014	-		-	-		-

A summary of the Company’s stock option activity by grant date as of September 30, 2014 is as follows:

	Options Outstanding						Options Vested
Options by Grant Date	Shares	Weighted Avg.		Remain. Life	Intrinsic Val		Shares	Weighted Avg.		Remain. Life	Intrinsic Val
Dec 2005	29,500	$	2.88	1.3	$	30,090	29,500	$	2.88	1.3	$	30,090
Dec 2010	72,000		6.14	1.3		-	39,750		5.97	1.3		-
Jan 2011	8,000		5.96	1.3		-	5,332		5.96	1.3		-
Nov 2012	109,000		5.17	3.2		-	43,600		5.17	3.2		-
Nov 2013	10,000		5.75	4.1		-	2,000		5.75	4.1		-
TOTAL	228,500	$	5.23	2.3	$	30,090	120,182	$	4.92	2.0	$	30,090

The aggregate intrinsic value in the tables above represents the total pre-tax intrinsic value (the difference between the closing price of the Company’s common stock on the last trading day of the quarter ended September 30, 2014 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all the holders exercised their options on September 30, 2014.

XML

Other Comprehensive Income (Details Textual) (USD $)	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014
Accumulated Other Comprehensive Income (Loss) [Line Items]
Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Tax	$ 363,000	$ 552,000

XML

Other Comprehensive Income (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Accumulated Other Comprehensive Income (Loss) [Line Items]
Foreign Currency Items, Beginning balance			$ (2,253,501)
Foreign Currency Items, Current period change, net of tax	(363,410)	(50,338)	(552,014)	119,894
Foreign Currency Items, Ending Balance	(2,805,515)		(2,805,515)
Total Accumulated Other Comprehensive Loss, Beginning balance			(2,253,501)
Total Accumulated Other Comprehensive Loss, Current period change, net of tax			(552,014)
Total Accumulated Other Comprehensive Loss, Ending Balance	$ (2,805,515)		$ (2,805,515)

XML

Inventories, Net (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Inventory [Line Items]
Raw materials	$ 3,927,047	$ 3,342,528
Work in process	1,653,392	1,149,704
Finished goods	13,591,550	11,673,872
Allowance for excess quantities	(771,483)	(737,691)
Total inventories	$ 18,400,506	$ 15,428,413

XML

Geographic Segment Data (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013
Segment Reporting Information [Line Items]
Sales to outside customers	$ 14,569,309	$ 14,479,934	$ 42,648,515	$ 40,859,007
Total Assets	43,064,763		43,064,763		39,071,500
United States [Member]
Segment Reporting Information [Line Items]
Sales to outside customers	10,808,000	10,837,000	30,986,000	30,496,000
Total Assets	31,930,000		31,930,000		28,758,000
United Kingdom [Member]
Segment Reporting Information [Line Items]
Sales to outside customers	592,000	517,000	2,057,000	1,602,000
Total Assets	1,399,000		1,399,000		1,025,000
Europe [Member]
Segment Reporting Information [Line Items]
Sales to outside customers	380,000	282,000	1,182,000	709,000
Total Assets	1,370,000		1,370,000		1,145,000
Mexico [Member]
Segment Reporting Information [Line Items]
Sales to outside customers	2,789,000	2,844,000	8,424,000	8,052,000
Total Assets	$ 8,366,000		$ 8,366,000		$ 8,144,000

XML

Basis of Presentation

9 Months Ended

Sep. 30, 2014

Organization, Consolidation and Presentation Of Financial Statements [Abstract]

Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]

Note 1 - Basis of Presentation

The accompanying condensed (a) consolidated balance sheet as of December 31, 2013, which has been derived from audited consolidated financial statements, and (b) the unaudited interim condensed consolidated financial statements have been prepared and, in the opinion of management, contain all the adjustments (consisting of those of a normal recurring nature) considered necessary to present fairly the consolidated financial position and the consolidated statements of comprehensive income and consolidated cash flows for the periods presented in conformity with generally accepted accounting principles for interim consolidated financial information and the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America. Operating results for the three and nine months ended September 30, 2014 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2014. It is suggested that these condensed consolidated financial statements be read in conjunction with the consolidated financial statements and notes thereto included in the Company's annual report on Form 10-K for the fiscal year ended December 31, 2013.

Principles of consolidation and nature of operations:

The condensed consolidated financial statements include the accounts of CTI Industries Corporation and its wholly-owned subsidiaries, CTI Balloons Limited, CTI Helium, Inc. and CTF International S.A. de C.V., its majority-owned subsidiaries CTI Mexico S.A. de C.V., Flexo Universal, S.A. de C.V. and CTI Europe gmbH, as well as the accounts of Venture Leasing S. A. de R. L., Venture Leasing L.L.C and Clever Container Company, L.L.C. (the “Company”). The last three entities have been consolidated as variable interest entities. Clever Container Company, L.L.C. has been consolidated since the beginning of the fourth quarter of 2013. All significant intercompany transactions and accounts have been eliminated in consolidation. The Company (i) designs, manufactures and distributes balloon products throughout the world and (ii) operates systems for the production, lamination, coating and printing of films used for food packaging and other commercial uses and for conversion of films to flexible packaging containers and other products.

Variable Interest Entities (“VIE’s”):

The determination of whether or not to consolidate a variable interest entity under U.S. GAAP requires a significant amount of judgment concerning the degree of control over an entity by its holders of variable interest. To make these judgments, management has conducted an analysis of the relationship of the holders of variable interest to each other, the design of the entity, the expected operations of the entity, which holder of variable interests is most “closely associated” to the entity and which holder of variable interests is the primary beneficiary required to consolidate the entity. Upon the occurrence of certain events, management reviews and reconsiders its previous conclusion regarding the status of an entity as a variable interest entity. There are three entities that have been consolidated as variable interest entities.

Use of estimates:

In preparing condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amount of revenue and expenses during the reporting period in the condensed consolidated financial statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include reserves for doubtful accounts, reserves for the lower of cost or market of inventory, reserves for deferred tax assets and recovery value of goodwill.

Earnings per share:

Basic earnings per share is computed by dividing net income by the weighted average number of shares of common stock outstanding during each period.

Diluted earnings per share is computed by dividing the net income by the weighted average number of shares of common stock and equivalents (stock options and warrants), unless anti-dilutive, during each period.

As of September 30, 2014 and 2013, shares to be issued upon the exercise of options and warrants aggregated 368,548 and 358,648, respectively. The number of anti-dilutive shares (not included in the determination of earnings on a diluted basis) for the three months ended September 30, 2014 and 2013, were 199,000 and 189,000, respectively, all of which were represented by options. The number of anti-dilutive shares for the nine months ended September 30, 2014 and 2013, were 199,000 and 80,000, respectively, all of which were represented by options.

Significant Accounting Policies:

The Company’s significant accounting policies are summarized in Note 2 of the Company’s consolidated financial statements for the year ended December 31, 2013. There were no significant changes to these accounting policies during the three and nine months ended September 30, 2014.

Recent Accounting Pronouncements:

In May 2014, the Financial Accounting Standards Board (FASB) issued guidance on the recognition of revenue from contracts with customers. Revenue recognition will depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The guidance also requires disclosures regarding the nature, amount, timing and uncertainty of revenue and cash flows arising from contracts with customers. The guidance permits two methods of adoption: retrospectively to each prior reporting period presented or retrospectively with the cumulative effect of initially applying the guidance recognized at the date of initial application. The guidance is effective January 1, 2017 and early adoption is not permitted. The company is currently evaluating the impact of the new guidance and the method of adoption in the consolidated financial results.

In August 2014, the FASB issued Accounting Standards Update (“ASU”) No. 2014-15, “Presentation of Financial Statements-Going Concern (Topic 205-40)” (“ASU 2014-15”). Under the standard, management is required to evaluate for each annual and interim reporting period whether it is a probable that the entity will not be able to meet its obligations as they become due within one year after the date that financial statements are issued, or are available to be issued, where applicable. ASU 2014-15 is effective for fiscal years, and interim periods within those years, beginning after December 15, 2016, and early adoption is permitted. Accordingly, the standard is effective for the Company on January 1, 2017. The Company does not believe that the pronouncement will have an impact on the Company's financial statements.

XML

Concentration of Credit Risk (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net Sales	$ 14,569,309	$ 14,479,934	$ 42,648,515	$ 40,859,007
Concentration Risk, Percentage	10.00%	10.00%	10.00%	10.00%
Customer A [Member]
Net Sales	3,369,000	3,002,000	11,299,000	11,412,000
Concentration Risk, Percentage	23.10%	20.70%	26.50%	27.90%
customer B [Member]
Net Sales	2,420,000	1,977,000	5,583,000	4,658,000
Concentration Risk, Percentage	16.60%	13.70%	13.10%	11.40%
Customer C [Member]
Net Sales	$ 0	$ 1,884,000
Concentration Risk, Percentage	0.00%	13.00%

XML

Condensed Consolidated Balance Sheets (USD $)	Sep. 30, 2014	Dec. 31, 2013
Current assets:
Cash and cash equivalents (VIE $26,000 and $54,000, respectively)	$ 171,843	$ 666,616
Accounts receivable, (less allowance for doubtful accounts of $263,000 and $217,000, respectively) (VIE $6,000 and $0, respectively)	11,114,047	8,883,106
Inventories, net (VIE $724,000 and $390,000, respectively)	18,400,506	15,428,413
Net deferred income tax asset	836,792	931,245
Prepaid expenses (VIE $3,000 and $3,000, respectively)	1,181,254	1,315,384
Other current assets (VIE $74,000 and $76,000, respectively)	706,459	945,914
Total current assets	32,410,901	28,170,678
Property, plant and equipment:
Machinery and equipment (VIE $700,000 and $723,000, respectively)	27,187,213	26,639,722
Building	3,360,017	3,360,017
Office furniture and equipment (VIE $44,000 and $39,000, respectively)	3,463,299	3,287,951
Intellectual property	482,088	482,088
Land	250,000	250,000
Leasehold improvements	655,720	586,515
Fixtures and equipment at customer locations	3,012,013	2,784,419
Projects under construction	793,236	1,009,623
Property, plant and equipment, gross	39,203,586	38,400,335
Less: accumulated depreciation and amortization (VIE $128,000 and $92,000, respectively)	(31,191,753)	(29,718,564)
Total property, plant and equipment, net	8,011,833	8,681,771
Other assets:
Deferred financing costs, net	147,601	197,585
Goodwill (VIE $440,000 and $440,000, respectively)	1,473,176	1,473,176
Net deferred income tax asset	858,434	317,639
Other assets (due from related party $23,000 and $24,000, respectively)	162,818	230,651
Total other assets	2,642,029	2,219,051
TOTAL ASSETS	43,064,763	39,071,500
Current liabilities:
Checks written in excess of bank balance (VIE $3,000 and $0, respectively)	1,044,151	704,757
Trade payables (VIE $120,000 and $94,000, respectively)	5,579,077	3,573,007
Line of credit (VIE $497,000 and $219,000, respectively)	11,654,227	8,769,024
Notes payable - current portion (net discount of $141,000 and $125,000, repectively) (VIE $112,000 and $107,000, respectively)	332,710	342,931
Notes payable affiliates - current portion	9,604	9,079
Capital Lease - current portion	32,084	30,487
Accrued liabilities (VIE $78,000 and $73,000, respectively)	2,473,569	3,003,704
Total current liabilities	21,125,422	16,432,989
Long-term liabilities:
Notes payable - affiliates	282,044	281,148
Notes payable, net of current portion (net discount of $322,000 and $430,000, repectively) (VIE $351,000 and $441,000, respectively)	7,258,199	7,511,383
Notes payable - officers, subordinated	1,215,748	1,155,705
Capital Lease	85,404	109,670
Total long-term debt, net of current portion	8,841,395	9,057,906
Warrants Payable	544,787	816,480
Total long-term liabilities	9,386,182	9,874,386
CTI Industries Corporation stockholders' equity:
Preferred Stock - no par value 2,000,000 shares authorized 0 shares issued and outstanding	0	0
Common stock - no par value, 5,000,000 shares authorized, 3,376,743 and 3,320,773 shares issued and 3,301,116 and 3,248,646 outstanding, respectively	13,585,994	13,775,994
Paid-in-capital	1,715,738	1,165,549
Accumulated earnings	241,587	109,137
Accumulated other comprehensive loss	(2,805,515)	(2,253,501)
Less: Treasury stock, 75,627 and 72,127 shares, respectively	(160,784)	(141,289)
Total CTI Industries Corporation stockholders' equity	12,577,020	12,655,890
Noncontrolling interest	(23,861)	108,235
Total Equity	12,553,159	12,764,125
TOTAL LIABILITIES AND EQUITY	$ 43,064,763	$ 39,071,500

XML

Condensed Consolidated Statements of Cash Flows [Parenthetical] (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Repayment of related party debt	$ 4,000	$ 32,000

XML

Derivative Instruments; Fair Value (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest Rate Swap	$ 0	$ 60,000
Warrant Liability	545,000	816,000
Liabilities, Fair Value Disclosure	545,000	876,000
Fair Value, Inputs, Level 1 [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest Rate Swap		0
Warrant Liability	0	0
Liabilities, Fair Value Disclosure	0
Fair Value, Inputs, Level 2 [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest Rate Swap		60,000
Warrant Liability	545,000	816,000
Liabilities, Fair Value Disclosure	545,000	876,000
Fair Value, Inputs, Level 3 [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Interest Rate Swap		0
Warrant Liability		0
Liabilities, Fair Value Disclosure	$ 0

XML

Derivative Instruments; Fair Value (Tables)

9 Months Ended

Sep. 30, 2014

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block]

The following tables represents information about the Company’s assets and liabilities measured at fair value on a recurring basis as of September 30, 2014 and December 30, 2013, and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value:

	Amount as of
Description	9/30/2014		Level 1		Level 2		Level 3
Warrant Liability		545,000		-		545,000
	$	545,000	$	-	$	545,000	$	-

	Amount as of
Description	12/31/2013		Level 1		Level 2		Level 3
Interest Rate Swap	$	60,000	$	-	$	60,000	$	-
Warrant Liability		816,000		-		816,000		-
	$	876,000			$	876,000

Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block]

Fair Values of Derivative Instruments in the Statement of Financial Position

	Liability Derivatives as of
	September 30, 2014			December 31, 2013
	Balance			Balance
Derivatives not designated as hedging	Sheet			Sheet
instruments under Statement 133	Location	Fair Value		Location	Fair Value
				Accrued
Interest Rate Contracts	Accrued Liabilities	$	-	Liabilities	$	60,000

Schedule of Derivative Instruments, Gain (Loss) in Statement of Financial Performance [Table Text Block]

The Effect of Derivative Instruments on the Statement of Financial Performance

	For the three months ended
	September 30, 2014			September 30, 2013
	Location of	Amount of		Location of	Amount of
Derivatives not Designated as Hedging	Gain (Loss) Recognized in Income on	Gain (Loss) Recognized in Income on		Gain (Loss) Recognized in Income on	Gain (Loss) Recognized in Income on
Instruments under Statement 133	Derivative	Derivative		Derivative	Derivative
Interest Rate Contracts	Interest Expense	$	-	Interest Expense	$	(3,000)
Interest on fixed/variable rate variances		$	21,000		$	21,000

The Effect of Derivative Instruments on the Statement of Financial Performance

	For the nine months ended
	September 30, 2014			September 30, 2013
	Location of	Amount of		Location of	Amount of
Derivatives not Designated as Hedging	Gain (Loss) Recognized in Income on	Gain (Loss) Recognized in Income on		Gain (Loss) Recognized in Income on	Gain (Loss) Recognized in Income on
Instruments under Statement 133	Derivative	Derivative		Derivative	Derivative
Interest Rate Contracts	Interest Expense	$	3,000	Interest Expense	$	(12,000)
Interest on fixed/variable rate variances		$	63,000		$	61,000

XML

Derivative Instruments; Fair Value (Details 1) (USD $)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2014	Dec. 31, 2013
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivatives not designated as hedging instruments under Statement 133	Interest Rate Contracts	Interest Rate Contracts
Balance Sheet Location		Accrued Liabilities	Accrued Liabilities
Fair Value	$ 0	$ 0	$ 60,000

XML

Stock-Based Compensation; Changes in Equity (Details) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Outstanding (in shares)	228,500
Shares, Exercisable (in shares)	120,182
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 5.23
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 4.92
Weighted Average Remaining Contractual Life, Outstanding (in years)	2 years 3 months 18 days	8 years 6 months
Weighted Average Remaining Contractual Life, Exercisable (in years)	2 years
Aggregate Intrinsic Value Outstanding (in dollars)	$ 30,090
Aggregate Intrinsic Value, Exercisable (in dollars)	30,090
Employee Stock Option [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Balance (in shares)	228,500
Shares, Granted (in shares)	0
Shares, Cancelled (in shares)	0
Shares, Exercised (in shares)	0
Shares, Outstanding (in shares)	228,500	228,500
Shares, Exercisable (in shares)	120,182
Weighted Average Exercise Price, Balance (in dollars per share)	$ 5.23
Weighted Average Exercise Price, Granted (in dollars per share)	$ 0
Weighted Average Exercise Price, Cancelled (in dollars per share)	$ 0
Weighted Average Exercise Price, Exercised (in dollars per share)	$ 0
Weighted Average Exercise Price, Outstanding (in dollars per share)	$ 5.23	$ 5.23
Weighted Average Exercise Price, Exercisable (in dollars per share)	$ 4.92
Weighted Average Remaining Contractual Life, Outstanding (in years)	2 years 3 months 18 days	3 years
Weighted Average Remaining Contractual Life, Exercisable (in years)	2 years
Aggregate Intrinsic Value Outstanding (in dollars)	161,250
Aggregate Intrinsic Value Outstanding (in dollars)	30,090	161,250
Aggregate Intrinsic Value, Exercisable (in dollars)	$ 30,090

XML

Condensed Consolidated Earnings per Share (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Basic
Weighted average number of common shares outstanding (in shares)	3,301,116	3,248,646	3,284,023	3,248,646
Net income:
Net income attributable to CTI Industries Corporation	$ 209,515	$ 234,324	$ 132,450	$ 308,678
Per share amount (in dollars per share)	$ 0.06	$ 0.07	$ 0.04	$ 0.10
Diluted
Weighted average number of common shares outstanding (in shares)	3,301,116	3,248,646	3,284,023	3,248,646
Effect of dilutive shares (in shares)	149,228	152,648	152,101	155,463
Weighted average number of shares and equivalent shares of common stock outstanding	3,450,344	3,401,294	3,436,124	3,404,109
Net income:
Net income attributable to CTI Industries Corporation	$ 209,515	$ 234,324	$ 132,450	$ 308,678
Per share amount (in dollars per share)	$ 0.06	$ 0.07	$ 0.04	$ 0.09

XML

Condensed Consolidated Balance Sheets [Parenthetical] (USD $)	Sep. 30, 2014	Dec. 31, 2013
Cash and cash equivalents	$ 171,843	$ 666,616
Allowance for doubtful accounts	263,000	217,000
Inventory, net	18,400,506	15,428,413
Prepaid expenses	1,181,254	1,315,384
Other current assets	706,459	945,914
Machinery and equipment	27,187,213	26,639,722
Office furniture and equipment	3,463,299	3,287,951
Accumulated depreciation and amortization	31,191,753	29,718,564
Goodwill	1,473,176	1,473,176
Due from related party	23,000	24,000
Checks written in excess of bank balance	1,044,151	704,757
Trade payables	5,579,077	3,573,007
Line of credit	11,654,227	8,769,024
Discount on notes payable current	141,000	125,000
Accrued liabilities	2,473,569	3,003,704
Notes Payable, net of current portion, net discount	322,000	430,000
Notes payable, net of current portion	7,258,199	7,511,383
Preferred Stock, shares authorized (in shares)	2,000,000	2,000,000
Preferred Stock, shares issued (in shares)	0	0
Preferred Stock, shares outstanding (in shares)	0	0
Common stock, shares authorized (in shares)	5,000,000	5,000,000
Common stock, shares issued (in shares)	3,376,743	3,320,773
Common stock, shares outstanding (in shares)	3,301,116	3,248,646
Treasury stock, shares (in shares)	75,627	72,127
Variable Interest Entity, Primary Beneficiary [Member]
Cash and cash equivalents	26,000	54,000
Allowance for doubtful accounts	6,000	0
Inventory, net	724,000	390,000
Prepaid expenses	3,000	3,000
Other current assets	74,000	76,000
Machinery and equipment	700,000	723,000
Office furniture and equipment	44,000	39,000
Accumulated depreciation and amortization	128,000	92,000
Goodwill	440,000	440,000
Checks written in excess of bank balance	3,000	0
Trade payables	120,000	94,000
Line of credit	497,000	219,000
Discount on notes payable current	112,000	107,000
Accrued liabilities	78,000	73,000
Notes payable, net of current portion	$ 351,000	$ 441,000

XML

Stock-Based Compensation; Changes in Equity (Tables)

9 Months Ended

Sep. 30, 2014

Disclosure of Compensation Related Costs, Share-based Payments [Abstract]

Schedule of Share-based Compensation, Stock Options, Activity [Table Text Block]

A summary of the Company’s stock option activity and related information is as follows:

		Weighted		Weighted
	Shares	Average		Average	Aggregate
	under	Exercise		Remaining Contractual	Intrinsic
	Option	Price		Life	Value
Balance at December 31, 2013	228,500	$	5.23	3.0	$	161,250
Granted	-		-
Cancelled	-		-
Exercised	-		-
Outstanding at September 30, 2014	228,500	$	5.23	2.3	$	30,090
Exercisable at September 30, 2014	120,182	$	4.92	2.0	$	30,090

Schedule of Stockholders Equity Note, Warrants or Rights [Table Text Block]

A summary of the Company’s stock warrant activity and related information is as follows:

		Weighted		Weighted
	Shares	Average		Average	Aggregate
	under	Exercise		Remaining Contractual	Intrinsic
	Warrant	Price		Life	Value
Balance at December 31, 2013	140,048	$	0.01	8.5	$	816,480
Granted
Cancelled	-		-
Exercised	-		-
Outstanding at September 30, 2014	140,048	$	0.01	7.8	$	544,787
Exercisable at September 30, 2014	-		-	-		-

Schedule Of Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding By Grant Date [Table Text Block]

A summary of the Company’s stock option activity by grant date as of September 30, 2014 is as follows:

	Options Outstanding						Options Vested
Options by Grant Date	Shares	Weighted Avg.		Remain. Life	Intrinsic Val		Shares	Weighted Avg.		Remain. Life	Intrinsic Val
Dec 2005	29,500	$	2.88	1.3	$	30,090	29,500	$	2.88	1.3	$	30,090
Dec 2010	72,000		6.14	1.3		-	39,750		5.97	1.3		-
Jan 2011	8,000		5.96	1.3		-	5,332		5.96	1.3		-
Nov 2012	109,000		5.17	3.2		-	43,600		5.17	3.2		-
Nov 2013	10,000		5.75	4.1		-	2,000		5.75	4.1		-
TOTAL	228,500	$	5.23	2.3	$	30,090	120,182	$	4.92	2.0	$	30,090

XML

Document And Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 01, 2014
Document Information [Line Items]
Entity Registrant Name	CTI INDUSTRIES CORP
Entity Central Index Key	0001042187
Current Fiscal Year End Date	--12-31
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		3,301,116
Trading Symbol	CTIB
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2014
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2014

XML

Other Comprehensive Income (Tables)

9 Months Ended

Sep. 30, 2014

Stockholders' Equity Note [Abstract]

Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block]

The following table sets forth the accumulated balance of other comprehensive loss and each component.

			Total
			Accumulated Other
	Foreign Currency Items		Comprehensive Loss
Beginning balance as of January 1, 2014	$	(2,253,501)	$	(2,253,501)
Current period change, net of tax		(552,014)		(552,014)
Ending Balance as of September 30, 2014	$	(2,805,515)	$	(2,805,515)

XML

Condensed Consolidated Statements of Comprehensive Income (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net Sales	$ 14,569,309	$ 14,479,934	$ 42,648,515	$ 40,859,007
Cost of Sales	10,824,765	11,182,419	32,380,526	32,105,384
Gross profit	3,744,544	3,297,515	10,267,989	8,753,623
Operating expenses:
General and administrative	1,623,858	1,616,263	5,498,835	4,562,322
Selling	1,006,080	553,482	2,333,524	1,448,897
Advertising and marketing	595,622	461,991	1,646,395	1,255,339
Total operating expenses	3,225,560	2,631,736	9,478,754	7,266,558
Income from operations	518,984	665,779	789,235	1,487,065
Other (expense) income:
Interest expense	(241,218)	(309,372)	(760,602)	(988,657)
Interest income	5,536	5,536	18,452	16,607
Foreign currency gain	8,049	40,641	5,568	14,343
Total other expense, net	(227,633)	(263,195)	(736,582)	(957,707)
Net income before taxes	291,351	402,584	52,653	529,358
Income tax expense	122,202	162,362	36,299	223,762
Net income	169,149	240,222	16,354	305,596
Less: Net (loss) income attributable to noncontrolling interest	(40,366)	5,898	(116,096)	(3,082)
Net income attributable to CTI Industries Corporation	209,515	234,324	132,450	308,678
Other Comprehensive (Loss) Income
Foreign currency adjustment	(363,410)	(50,338)	(552,014)	119,894
Comprehensive (loss) income	$ (153,895)	$ 183,986	$ (419,564)	$ 428,572
Basic income per common share (in dollars per share)	$ 0.06	$ 0.07	$ 0.04	$ 0.10
Diluted income per common share (in dollars per share)	$ 0.06	$ 0.07	$ 0.04	$ 0.09
Weighted average number of shares and equivalent shares of common stock outstanding:
Basic (in shares)	3,301,116	3,248,646	3,284,023	3,248,646
Diluted (in shares)	3,450,344	3,401,294	3,436,124	3,404,109

XML

Inventories, Net

9 Months Ended

Sep. 30, 2014

Inventory Disclosure [Abstract]

Inventory Disclosure [Text Block]

Note 5 - Inventories, Net

	September 30,
	2014		December 31, 2013
Raw materials	$	3,927,047	$	3,342,528
Work in process		1,653,392		1,149,704
Finished goods		13,591,550		11,673,872
Allowance for excess quantities		(771,483)		(737,691)
Total inventories	$	18,400,506	$	15,428,413

XML

Other Comprehensive Income

9 Months Ended

Sep. 30, 2014

Stockholders' Equity Note [Abstract]

Comprehensive Income (Loss) Note [Text Block]

Note 4 - Other Comprehensive Income

In the three and nine months ended September 30, 2014 the company had a comprehensive loss of $363,000 and a comprehensive loss of $552,000, respectively, all from foreign currency translation adjustments.

The following table sets forth the accumulated balance of other comprehensive loss and each component.

			Total
			Accumulated Other
	Foreign Currency Items		Comprehensive Loss
Beginning balance as of January 1, 2014	$	(2,253,501)	$	(2,253,501)
Current period change, net of tax		(552,014)		(552,014)
Ending Balance as of September 30, 2014	$	(2,805,515)	$	(2,805,515)

XML

Basis of Presentation (Details Textual)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Shares To Be Issued Upon Exercise Of Options And Warrant	368,548	358,648	368,548	358,648
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount	199,000	189,000	199,000	80,000

XML

Inventories, Net (Tables)

9 Months Ended

Sep. 30, 2014

Inventory Disclosure [Abstract]

Schedule of Inventory, Current [Table Text Block]

	September 30,
	2014		December 31, 2013
Raw materials	$	3,927,047	$	3,342,528
Work in process		1,653,392		1,149,704
Finished goods		13,591,550		11,673,872
Allowance for excess quantities		(771,483)		(737,691)
Total inventories	$	18,400,506	$	15,428,413

XML

Related Party Transactions

9 Months Ended

Sep. 30, 2014

Related Party Transactions [Abstract]

Related Party Transactions Disclosure [Text Block]

Note 8 - Related Party Transactions

Stephen M. Merrick, President of the Company, is of counsel to the law firm of Vanasco Genelly and Miller PC which provides legal services to the Company. Legal fees paid by the Company to this firm for the three months ended September 30, 2014 and 2013, respectively, were $33,000 and $27,000. Legal fees paid by the Company to this firm for the nine months ended September 30, 2014 and 2013, respectively, were $84,000 and $89,000.

John H. Schwan, Chief Executive Officer of the Company, during a portion of 2013, was a principal of Shamrock Specialty Packaging and affiliated companies. The Company made payments for packaging materials supplied by Shamrock of approximately $487,000 during the three months ended September 30, 2014 and $265,000 during the three months ended September 30, 2013. The Company made payments for packaging materials supplied by Shamrock of approximately $1,506,000 during the nine months ended September 30, 2014 and $1,683,000 during the nine months ended September 30, 2013. At September 30, 2014 and 2013, outstanding accounts payable balances were $110,000 and $138,000, respectively.

John H. Schwan, Chief Executive Officer of the Company, is the brother of Gary Schwan, one of the owners of Schwan Incorporated, which provides building maintenance and remodeling services to the Company. The Company made payments to Schwan Incorporated of approximately $21,000 during the three months ended September 30, 2014 and $1,000 during the three months ended September 30, 2013. The Company made payments to Schwan Incorporated of approximately $21,000 during the nine months ended September 30, 2014 and $15,000 during the nine months ended September 30, 2013.

Interest payments have been made or accrued to John H. Schwan for loans made to the Company. During the three months ended September 30, 2014 and 2013 these interest payments totaled $20,000 and $19,000, respectively. During the nine months ended September 30, 2014 and 2013 these interest payments totaled $60,000 and $57,000, respectively.

On July 1, 2011, Flexo Universal, S.A. de C.V. (“Flexo”) entered into a lease agreement with Venture Leasing S.A. de R.L. (“Venture Leasing Mexico”) for the lease of balloon production equipment financed and owned by Venture Leasing Mexico and used by Flexo for the production of latex balloons. Venture Leasing Mexico is wholly owned by entities owned by John H. Schwan, Chief Executive Officer of the Company and Stephen M. Merrick, President of the Company. Venture Leasing Mexico and Venture Leasing L.L.C., also owned by entities owned by Mr. Schwan and Mr. Merrick, are deemed variable interest entities and are consolidated with the accounts of the Company. During the three and nine months ended September 30, 2014, Flexo made lease payments to Venture Leasing Mexico totaling $36,000 and $109,000. During the three and nine months ended September 30, 2013, Flexo made lease payments to Venture Leasing Mexico totaling $36,000 and $109,000.

XML

Geographic Segment Data

9 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Segment Reporting Disclosure [Text Block]

Note 6 - Geographic Segment Data

The Company has determined that it operates primarily in one business segment which designs, manufactures and distributes film and film related products for use in packaging, storage and novelty balloon products. The Company operates in foreign and domestic regions. Information about the Company's operations by geographic areas is as follows: 

	Net Sales to Outside				Net Sales to Outside
	Customers				Customers
	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
United States	$	10,808,000	$	10,837,000	$	30,986,000	$	30,496,000
Europe		380,000		282,000		1,182,000		709,000
Mexico		2,789,000		2,844,000		8,424,000		8,052,000
United Kingdom		592,000		517,000		2,057,000		1,602,000
	$	14,569,000	$	14,480,000	$	42,649,000	$	40,859,000

	Total Assets at
	September 30,		December 31,
	2014		2013
United States	$	31,930,000	$	28,758,000
Europe		1,370,000		1,145,000
Mexico		8,366,000		8,144,000
United Kingdom		1,399,000		1,025,000
	$	43,065,000	$	39,072,000

XML

Concentration of Credit Risk

9 Months Ended

Sep. 30, 2014

Risks and Uncertainties [Abstract]

Concentration Risk Disclosure [Text Block]

Note 7 - Concentration of Credit Risk

Concentration of credit risk with respect to trade accounts receivable is generally limited due to the large number of entities comprising the Company's customer base. The Company performs ongoing credit evaluations and provides an allowance for potential credit losses against the portion of accounts receivable which is estimated to be uncollectible. Such losses have historically been within management's expectations. During the three months ended September 30, 2014 and 2013, there were two and three customers whose purchases represented more than 10% of the Company’s consolidated net sales, respectively. During the nine months ended September 30, 2014 and 2013, there were two customers whose purchases represented more than 10% of the Company’s consolidated net sales, respectively. Sales to these customers for the three and nine months ended September 30, 2014 and 2013 are as follows:

	Three Months Ended				Three Months Ended
	September 30, 2014				September 30, 2013
			% of Net				% of Net
Customer	Net Sales		Sales		Net Sales		Sales
Customer A	$	3,369,000	23.1	%	$	3,002,000	20.7	%
Customer B	$	2,420,000	16.6	%	$	1,977,000	13.7	%
Customer C		N/A	N/A		$	1,884,000	13.0	%

	Nine Months Ended				Nine Months Ended
	September 30, 2014				September 30, 2013
			% of Net				% of Net
Customer	Net Sales		Sales		Net Sales		Sales
Customer A	$	11,299,000	26.5	%	$	11,412,000		27.9	%
Customer B	$	5,583,000	13.1	%	$	4,658,000		11.4	%

As of September 30, 2014, the total amounts owed to the Company by these customers were approximately $2,089,000 or 18.8%, and $2,430,000 or 21.9%, of the Company’s consolidated net accounts receivable, respectively. The amounts owed at September 30, 2013 by these customers were approximately $1,286,000 or 13.6%, $1,915,000 or 20.3%, and $1,054,000 or 11.2% of the Company’s consolidated net accounts receivable.

XML

Derivative Instruments; Fair Value

9 Months Ended

Sep. 30, 2014

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivatives and Fair Value [Text Block]

Note 9 - Derivative Instruments; Fair Value

The following tables represents information about the Company’s assets and liabilities measured at fair value on a recurring basis as of September 30, 2014 and December 30, 2013, and indicate the fair value hierarchy of the valuation techniques utilized by the Company to determine such fair value:

	Amount as of
Description	9/30/2014		Level 1		Level 2		Level 3
Warrant Liability		545,000		-		545,000
	$	545,000	$	-	$	545,000	$	-

	Amount as of
Description	12/31/2013		Level 1		Level 2		Level 3
Interest Rate Swap	$	60,000	$	-	$	60,000	$	-
Warrant Liability		816,000		-		816,000		-
	$	876,000			$	876,000

The Company is exposed to certain market risks including the effect of changes in interest rates. The Company uses derivative instruments to manage financial exposures that occur in the normal course of business. It does not hold or issue derivatives for speculative trading purposes. The Company is exposed to non-performance risk from the counterparties in its derivative instruments. This risk would be limited to any unrealized gains on current positions. To help mitigate this risk, the Company transacts only with counterparties that are rated as investment grade or higher and all counterparties are monitored on a continuous basis. The fair value of the Company’s derivatives reflects this credit risk.

On July 1, 2011, the Company entered into a swap agreement with BMO Capital Markets with respect to $6,780,000 of our loan balances with BMO Harris Bank N.A. This swap agreement limits the Company’s exposure to interest rate fluctuations on the Company’s floating rate loans. The swap agreement has the effect of fixing the interest rate on the loan balances covered by the swap at 4.65% per annum. The swap agreement is a derivative financial instrument and we determine and record the fair market value of the swap agreement each quarter. The value is recorded on the balance sheet of the Company and the amount of the unrealized gain or loss for each period is recorded as interest income or expense. The swap agreement has expired as of September 30, 2014.

Fair Values of Derivative Instruments in the Statement of Financial Position

	Liability Derivatives as of
	September 30, 2014			December 31, 2013
	Balance			Balance
Derivatives not designated as hedging	Sheet			Sheet
instruments under Statement 133	Location	Fair Value		Location	Fair Value
				Accrued
Interest Rate Contracts	Accrued Liabilities	$	-	Liabilities	$	60,000

The Effect of Derivative Instruments on the Statement of Financial Performance

	For the three months ended
	September 30, 2014			September 30, 2013
	Location of	Amount of		Location of	Amount of
Derivatives not Designated as Hedging	Gain (Loss) Recognized in Income on	Gain (Loss) Recognized in Income on		Gain (Loss) Recognized in Income on	Gain (Loss) Recognized in Income on
Instruments under Statement 133	Derivative	Derivative		Derivative	Derivative
Interest Rate Contracts	Interest Expense	$	-	Interest Expense	$	(3,000)
Interest on fixed/variable rate variances		$	21,000		$	21,000

The Effect of Derivative Instruments on the Statement of Financial Performance

	For the nine months ended
	September 30, 2014			September 30, 2013
	Location of	Amount of		Location of	Amount of
Derivatives not Designated as Hedging	Gain (Loss) Recognized in Income on	Gain (Loss) Recognized in Income on		Gain (Loss) Recognized in Income on	Gain (Loss) Recognized in Income on
Instruments under Statement 133	Derivative	Derivative		Derivative	Derivative
Interest Rate Contracts	Interest Expense	$	3,000	Interest Expense	$	(12,000)
Interest on fixed/variable rate variances		$	63,000		$	61,000

XML

Related Party Transactions (Details Textual) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Related Party Transaction [Line Items]
Legal Fees	$ 33,000	$ 27,000	$ 84,000	$ 89,000
Payments to Supplier	487,000	265,000	1,506,000	1,683,000
Accounts Payable	110,000	138,000	110,000	138,000
Lease Payment	36,000	36,000	109,000	109,000
John H Schwan [Member]
Related Party Transaction [Line Items]
Interest Expenses	20,000	19,000	60,000	57,000
Schwan Incorporated [Member]
Related Party Transaction [Line Items]
Related Party Transaction, Amounts of Transaction	$ 21,000	$ 1,000	$ 21,000	$ 15,000

XML

Concentration of Credit Risk (Tables)

9 Months Ended

Sep. 30, 2014

Risks and Uncertainties [Abstract]

Schedules of Concentration of Risk, by Risk Factor [Table Text Block]

Sales to these customers for the three and nine months ended September 30, 2014 and 2013 are as follows:

	Three Months Ended				Three Months Ended
	September 30, 2014				September 30, 2013
			% of Net				% of Net
Customer	Net Sales		Sales		Net Sales		Sales
Customer A	$	3,369,000	23.1	%	$	3,002,000	20.7	%
Customer B	$	2,420,000	16.6	%	$	1,977,000	13.7	%
Customer C		N/A	N/A		$	1,884,000	13.0	%

	Nine Months Ended				Nine Months Ended
	September 30, 2014				September 30, 2013
			% of Net				% of Net
Customer	Net Sales		Sales		Net Sales		Sales
Customer A	$	11,299,000	26.5	%	$	11,412,000		27.9	%
Customer B	$	5,583,000	13.1	%	$	4,658,000		11.4	%

XML

Stock-Based Compensation; Changes in Equity (Details 2) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Options Outstanding (in shares)	228,500
Weighted Average, Options Outstanding (in dollars per share)	$ 5.23
Remaining Life, Options Outstanding (in years)	2 years 3 months 18 days	8 years 6 months
Intrinsic Value, Options Outstanding (in dollars)	$ 30,090
Shares, Options Vested (in shares)	120,182
Weighted Average, Options Vested (in dollars per share)	$ 4.92
Remaining Life, Option Vested (in years)	2 years
Intrinsic Value, Options Vested (in dollars)	30,090
Stock Options By Grant Date Dec 2005 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Options Outstanding (in shares)	29,500
Weighted Average, Options Outstanding (in dollars per share)	$ 2.88
Remaining Life, Options Outstanding (in years)	1 year 3 months 18 days
Intrinsic Value, Options Outstanding (in dollars)	30,090
Shares, Options Vested (in shares)	29,500
Weighted Average, Options Vested (in dollars per share)	$ 2.88
Remaining Life, Option Vested (in years)	1 year 3 months 18 days
Intrinsic Value, Options Vested (in dollars)	30,090
Stock Options By Grant Date Dec 2010 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Options Outstanding (in shares)	72,000
Weighted Average, Options Outstanding (in dollars per share)	$ 6.14
Remaining Life, Options Outstanding (in years)	1 year 3 months 18 days
Intrinsic Value, Options Outstanding (in dollars)	0
Shares, Options Vested (in shares)	39,750
Weighted Average, Options Vested (in dollars per share)	$ 5.97
Remaining Life, Option Vested (in years)	1 year 3 months 18 days
Intrinsic Value, Options Vested (in dollars)	0
Stock Options By Grant Date Jan 2011 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Options Outstanding (in shares)	8,000
Weighted Average, Options Outstanding (in dollars per share)	$ 5.96
Remaining Life, Options Outstanding (in years)	1 year 3 months 18 days
Intrinsic Value, Options Outstanding (in dollars)	0
Shares, Options Vested (in shares)	5,332
Weighted Average, Options Vested (in dollars per share)	$ 5.96
Remaining Life, Option Vested (in years)	1 year 3 months 18 days
Intrinsic Value, Options Vested (in dollars)	0
Stock Options By Grant Date Nov 2012 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Options Outstanding (in shares)	109,000
Weighted Average, Options Outstanding (in dollars per share)	$ 5.17
Remaining Life, Options Outstanding (in years)	3 years 2 months 12 days
Intrinsic Value, Options Outstanding (in dollars)	0
Shares, Options Vested (in shares)	43,600
Weighted Average, Options Vested (in dollars per share)	$ 5.17
Remaining Life, Option Vested (in years)	3 years 2 months 12 days
Intrinsic Value, Options Vested (in dollars)	0
Stock Options By Grant Date Nov 2013 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Options Outstanding (in shares)	10,000
Weighted Average, Options Outstanding (in dollars per share)	$ 5.75
Remaining Life, Options Outstanding (in years)	4 years 1 month 6 days
Intrinsic Value, Options Outstanding (in dollars)	0
Shares, Options Vested (in shares)	2,000
Weighted Average, Options Vested (in dollars per share)	$ 5.75
Remaining Life, Option Vested (in years)	4 years 1 month 6 days
Intrinsic Value, Options Vested (in dollars)	$ 0

XML

Condensed Consolidated Statements of Cash Flows (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:
Net income	$ 16,354	$ 305,596
Adjustment to reconcile net income to cash provided by operating activities:
Depreciation and amortization	1,594,444	1,423,086
Amortization of debt discount	92,253	54,989
Change in value of swap agreement	(59,859)	(30,942)
Stock based compensation	60,189	93,632
Provision for losses on accounts receivable	79,943	94,862
Provision for losses on inventories	34,055	71,875
Deferred income taxes	(368,170)	(41,385)
Change in assets and liabilities:
Accounts receivable	(2,449,243)	(1,788,386)
Inventories	(3,164,333)	451,467
Prepaid expenses and other assets	412,969	335,209
Trade payables	2,020,513	(505,150)
Accrued liabilities	(1,119,859)	(89,353)
Net cash (used in) provided by operating activities	(2,850,744)	375,500
Cash used in investing activities - purchases of property, plant and equipment	(838,578)	(1,476,910)
Cash flows from financing activities:
Change in checks written in excess of bank balance	338,470	(360,069)
Net change in revolving line of credit	2,886,194	1,676,487
Proceeds from issuance of long-term debt	75,494	174,959
Repayment of long-term debt (related parties $4,000 and $32,000)	(387,487)	(374,111)
Cash paid for deferred financing fees	0	(30,704)
Purchase of treasury stock	(19,495)	0
Dividends paid	(16,000)	0
Proceeds from issuance of stock, net	300,000	0
Net cash provided by financing activities	3,177,176	1,086,562
Effect of exchange rate changes on cash	17,373	(3,726)
Net decrease in cash and cash equivalents	(494,773)	(18,574)
Cash and cash equivalents at beginning of period	666,616	351,064
Cash and cash equivalents at end of period	171,843	332,490
Supplemental disclosure of cash flow information:
Cash payments for interest	861,760	863,263
Cash payments for taxes	55,466	25,000
Supplemental Disclosure of non-cash investing and financing activity
Property, Plant & Equipment acquisitions funded by liabilities	$ 102,313	$ 86,299

XML

Legal Proceedings

9 Months Ended

Sep. 30, 2014

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies Disclosure [Text Block]

Note 3 - Legal Proceedings

On September 2, 2014, Amada Gonzalez and Leticia Ocampo, individually, and purportedly on behalf of a class of other persons similarly situated, filed and action in the United States District Court for the Northern District of Illinois against the Company, Ron’s Temporary Help Services, Inc., Prime Staffing, Inc. and Extreme Staffing Solution Corp. The individual plaintiffs are alleged to be persons who were employed by one of the temporary staffing companies named as defendants in the action and who worked at the Company’s facilities. The complaint includes claims of alleged violations of The Fair Labor Standards Act, the Illinois Wage Payment and Collection Act, The Illinois Minimum Wage Law and the Illinois Day and Temporary Labor Services Act, for alleged failure to pay minimum wages, overtime wages or vacation pay. Liability is asserted against the Company as an alleged “joint employer.” The complaint requests judgment for the amount of alleged unpaid wages, unspecified liquidated damages, attorney’s fees and injunctive relief. The Company has not yet responded to the complaint but intends vigorously to defend against all of the claims made. An estimate of the possible loss or range of loss with respect to this claim cannot be made.

In addition to the foregoing, the Company is party to certain claims or actions arising in the normal course of business. The ultimate outcome of these matters is unknown but, in the opinion of management, the resolution of these matters is not expected to have a significant effect on the future financial position or results of operations of the Company.

XML

Stock-Based Compensation; Changes in Equity (Details Textual) (USD $)	3 Months Ended		9 Months Ended						1 Months Ended		9 Months Ended		9 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014 Year 2014 [Member]	Sep. 30, 2014 Year 2015 [Member]	Sep. 30, 2014 Year 2016 [Member]	Sep. 30, 2014 Year 2017 [Member]	Jul. 31, 2012 BMO Equity [Member]	Jul. 17, 2012 BMO Equity [Member]	Sep. 30, 2014 Stock Option Plan 2001 [Member]	Apr. 12, 2001 Stock Option Plan 2001 [Member]	Sep. 30, 2014 Stock Option Plan 2002 [Member]	Apr. 24, 2002 Stock Option Plan 2002 [Member]	Sep. 30, 2014 Stock Incentive Plan 2009 [Member]	Apr. 10, 2009 Stock Incentive Plan 2009 [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate			0.00%	0.00%
Employee Service Share-based Compensation, Nonvested Awards, Total Compensation Cost Not yet Recognized	$ 60,000		$ 60,000
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized												119,050		142,860		250,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number											2,000		27,500		199,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross											139,958		123,430		201,000
Share-Based Compensation	17,000	24,000	60,189	93,632	17,000	29,000	11,000	3,000
Related Party Transaction, Due from (to) Related Party, Total										$ 5,000,000
Warrants Issued To Purchase Common Stock Percentage										4.00%
Weighted Average Number Of Shares Outstanding, Diluted	3,450,344	3,401,294	3,436,124	3,404,109					140,048
Earnings Per Share, Diluted	$ 0.06	$ 0.07	$ 0.04	$ 0.09					$ 0.01
Debt Instrument, Term									0 years
Debt Instrument, Interest Rate, Stated Percentage										11.50%

XML

Derivative Instruments; Fair Value (Details Textual) (Swap [Member], USD $)	Jul. 01, 2011
Swap [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Derivative Liability, Notional Amount	$ 6,780,000
Derivative, Swaption Interest Rate	4.65%

XML

Geographic Segment Data (Tables)

9 Months Ended

Sep. 30, 2014

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment [Table Text Block]

The Company operates in foreign and domestic regions. Information about the Company's operations by geographic areas is as follows: 

	Net Sales to Outside				Net Sales to Outside
	Customers				Customers
	For the Three Months Ended				For the Nine Months Ended
	September 30,				September 30,
	2014		2013		2014		2013
United States	$	10,808,000	$	10,837,000	$	30,986,000	$	30,496,000
Europe		380,000		282,000		1,182,000		709,000
Mexico		2,789,000		2,844,000		8,424,000		8,052,000
United Kingdom		592,000		517,000		2,057,000		1,602,000
	$	14,569,000	$	14,480,000	$	42,649,000	$	40,859,000

	Total Assets at
	September 30,		December 31,
	2014		2013
United States	$	31,930,000	$	28,758,000
Europe		1,370,000		1,145,000
Mexico		8,366,000		8,144,000
United Kingdom		1,399,000		1,025,000
	$	43,065,000	$	39,072,000